Despite the leak, the full data released later that day showed promising results for patients, meeting or exceeding Wall Street's expectations. The personalized vaccine, known as intismeran autogene, combines Moderna's technology with Merck's immunotherapy Keytruda to combat melanoma.

When administered alongside Keytruda, the vaccine significantly reduced the risk of cancer recurrence or death in certain melanoma patients by 42%. Additionally, it lowered the likelihood of cancer spreading to distant parts of the body or death by 38% compared to using just Keytruda.

The data also revealed that nearly 82% of patients who received the personalized cancer vaccine alongside Keytruda remained alive without their melanoma returning at two years post-treatment, a notable improvement over the 70% survival rate achieved with Keytruda alone.

The personalized cancer vaccine developed by Moderna and Merck has been shown to have a significant impact when combined with Keytruda, a widely used immunotherapy treatment for melanoma.

One notable advantage of this combination is its relatively mild side effects compared to other cancer treatments. Injection-site pain was the most common adverse reaction reported in patients who received the vaccine alongside Keytruda.

The phase 3 trial results are set to be presented at the European Society for Medical Oncology conference, but they have already been leaked ahead of time. The data suggests that the combination therapy is highly effective in preventing melanoma recurrence and death.

Analysts have weighed in on the implications of the leaked data, with some noting that investors' expectations may have been overly optimistic. Despite this, several experts agree that the results are overall positive and demonstrate a clinically meaningful reduction in the risk of recurrence or death.

The targeted vaccine's potential to treat various forms of cancer has generated significant interest among oncologists and investors, who see it as a possible breakthrough treatment in this field.

Merck and Moderna are currently conducting trials across different tumor types, including non-small cell lung cancer, bladder cancer, and renal cell carcinoma. These studies aim to demonstrate the vaccine's efficacy beyond its initial success in treating a specific type of skin cancer. While some progress has been made, experts agree that more work is needed to fully understand the vaccine's potential.

The approach taken by Moderna involves targeting specific mutations within each patient's tumor, rather than using a one-size-fits-all method. This personalized strategy aims to train the immune system to recognize and attack unique cancer markers, which can then be paired with other treatments like Keytruda to enhance its effectiveness.

A successful commercialization of this vaccine could provide Moderna with a crucial new product in its pipeline, complementing its existing vaccines for Covid-19, flu, and respiratory syncytial virus.

Moderna's shares have plummeted despite positive results from its cancer vaccine data. This downturn may be attributed to excessively high expectations surrounding the company's performance. The latest data release has provided a boost of confidence for upcoming studies involving kidney and bladder cancers.

UBS analysts have been closely following Moderna's progress and have expressed optimism about the vaccine's prospects. They attribute the negative market reaction to unrealistic expectations rather than disappointing results. As a result, investors may be overreacting to what appears to be encouraging data from the company.

The contrast between Moderna's performance and that of its rival, Merck, is striking. While shares of Merck fell by about 1% on Thursday, it has still managed to climb nearly 41% this year. This divergence highlights the intense scrutiny under which Moderna operates, with investors eagerly awaiting every development in the company's pipeline.

CNBC: https://www.cnbc.com/2026/10/22/moderna-stock-cancer-vaccine-data-leak.html

The trial's lead researcher, Christine Stabell Benn of Bandim Health Project and the University of Southern Denmark, confirmed in an email that Guinea-Bissau's Council of Ministers formally rejected the study on October 16th. This move comes after weeks of controversy surrounding the trial.

A recent development in this saga is the raid by judicial police in Guinea-Bissau on Bandim Health's offices, where they seized vaccines. Stabell Benn pointed out that the police action took place shortly after the government rejected the study proposal.

The researcher expressed regret over the decision to reject the study, stating that it was deemed scientifically and ethically justified by her team. However, she acknowledged the authority of the government in deciding whether research can proceed within their country's borders.

Experts from various fields have questioned the trial's justification and design, labeling it as "unethical due to its plan to withhold the newborn dose of hepatitis B vaccine from half of the participants.

The trial's cancellation comes as a relief for thousands of babies in Guinea-Bissau who would have been at risk of developing chronic hepatitis B infections if the study had proceeded.

The country has struggled with high rates of hepatitis B infections, which can lead to severe health consequences such as liver cirrhosis and cancer. In light of this, experts argue that there is no scientific justification for a trial that would withhold the newborn dose of the vaccine from half of the participants.

The researchers behind the study, Bandim Health's Stabell Benn and her husband Peter Aaby, have been at the center of controversy in the past. Their work on nonspecific harms from vaccines has been lauded by anti-vaccine advocates, but criticized by their peers for its quality.

Aaby and Stabell Benn are currently under investigation by Danish authorities for alleged scientific misconduct in their previous studies. The investigation adds to concerns about the ethics of the hepatitis B vaccine trial that was planned to take place in Guinea-Bissau.

The US CDC's decision to award an unsolicited grant of $1.6 million to Bandim Health has also sparked outrage, with some questioning the motivations behind the funding.

The controversy surrounding the hepatitis B vaccine trial on newborns in Guinea-Bissau continues to escalate, with outside experts questioning the ethics of withholding proven care from participants.

In response to criticism, Stabell Benn and colleagues have maintained that their approach is justified because Guinea-Bissau does not currently offer routine hepatitis B vaccinations at birth. They argue that without the trial, these newborns would not have received the vaccine anyway, as it is only planned for introduction in 2028 due to a lack of resources and infrastructure.

However, experts point out that this reasoning contradicts established guidelines such as the Declaration of Helsinki, which requires trials to provide participants with the best proven intervention available. In the case of hepatitis B prevention, this means administering the newborn dose within the first 24 hours of life, as recommended globally.

The World Health Organization has explicitly stated that resource constraints cannot be used to justify withholding proven care in a research study involving people. This stance is at odds with Stabell Benn and colleagues' approach, which appears to prioritize cost-effectiveness over the well-being of trial participants.

A Bandim Health researcher involved in the trial, Frederik Schaltz-Buchholzer, has tried to deflect criticism by blaming the Anglophone media" for framing the trial as dangerous due to its control group.

The controversy surrounding the US-backed vaccine trial on babies in Guinea-Bissau has led to a breakdown in trust between local officials and researchers involved in the project.

Rumors have been circulating on social media that the trial was actually testing a novel vaccine, with some speculating that the hepatitis B vaccine is dangerous and that Guinea-Bissau newborns are being used as test subjects. These concerns were fueled by negative media coverage of the trial.

Despite claims from researchers that the media controversy has led to misplaced fears about the safety of the hepatitis B vaccine in Guinea-Bissau, local distrust towards the researchers may have played a role in the rejection of the trial and subsequent police operation.

The Council of Ministers had instructed authorities to investigate the origin and handling of vaccines intended for the proposed study, leading to a search of the Bandim Health Project premises on October 19. The Judicial Police sealed a fridge containing a batch of hepatitis B vaccines meant for the trial.

No vaccines were administered during the trial as it had not yet begun, but local officials seem unconvinced by the researchers' claims that they cooperated fully with authorities during the investigation.

The US-backed vaccine trial for babies has been canceled due to international outcry. The decision was made by Stabell Benn, who stated that any future proposal would have to undergo thorough scientific, ethical, and governmental reviews.

Bandim has ruled out moving the trial to a different location. According to Benn, the underlying scientific question remains important but must be addressed in an appropriate local context with proper partnership and regulatory oversight. The cancellation marks a conclusion to this contentious issue.

Ars Technica: https://arstechnica.com/health/2026/10/unethical-vaccine-trial-on-babies-backed-by-rfk-jr-is-formally-canceled/

For Adrianne, who works in digital marketing in London, the condition has been a constant companion for nearly five years. It took her two years to get a diagnosis, during which time she was misdiagnosed with colon cancer, Crohn's disease, and even given false accusations about her partner's infidelity.

Adrianne's experience is not unique, as many women have shared their struggles with chronic UTIs on social media platforms like TikTok and Instagram. They describe the condition as a debilitating cycle that has stripped them of their ability to work properly, maintain relationships, and enjoy normal social lives.

Experts estimate that up to 1.7 million women in the UK could be affected by chronic UTIs, but this number may be an underestimate due to the stigma surrounding the condition. Men and children are also affected, although the prevalence among women is significantly higher.

Adrianne's decision to share her story on social media has been a way for her to cope with the condition and raise awareness about its impact. By doing so, she hopes to help others who may be struggling in silence due to the shame and stigma associated with living with a chronic UTI.

Adrianne's decision to share her struggles with chronic urinary tract infections (UTIs) on social media has sparked a positive response from others who are experiencing similar symptoms.

The condition is characterized by persistent infection and pain despite standard treatment with antibiotics, leaving some women feeling trapped in their own bodies.

Those affected often experience debilitating abdominal pain that can be unpredictable and vary in intensity, ranging from mild discomfort to excruciating spasms.

Women living with chronic UTIs may also struggle with frequent urination, which can become a source of distress as they navigate daily life, always worried about having a flare-up.

As experts note, diagnosing chronic UTIs can be challenging due to the possibility of false negatives when relying on urine samples, and the condition often overlaps with other conditions such as endometriosis.

Adrianne's experience of being dismissed by doctors while seeking a diagnosis for her recurring urinary tract infections (UTIs) is not an isolated one. Many women face similar frustrations when trying to get their symptoms taken seriously.

Health professionals are now emphasizing the importance of listening to patients' stories in order to accurately diagnose chronic conditions such as recurrent or persistent UTIs. By doing so, they can avoid giving general advice on hygiene and hydration that fails to address the underlying issue.

The online community has become a crucial source of support for women like Adrianne who feel stigmatized by their condition. Social media platforms are filled with stories from young women who worry about being "dirty" or "not taking care of themselves," highlighting the need for education on UTIs and their causes.

Laura Von Müllen, another woman living with a chronic UTI, has taken to TikTok to share her experiences. She notes that her symptoms not only affected her university studies but also became increasingly difficult to manage when she started working remotely from Kent.

The stigma surrounding urinary tract infections (UTIs) is slowly being dismantled as women share their personal experiences on social media, but misconceptions still persist.

Some people mistakenly believe that UTIs are a result of promiscuity, with others asking who the individual has been in relationships with. However, this assumption is not only unfounded but also stigmatizing.

Experts agree that discussing conditions like UTIs openly can help reduce the number of women suffering from undiagnosed or mismanaged infections.

When seeking information online, individuals must be cautious as they may come across misinformation and unproven "hacks" that could exacerbate their condition.

BBC News Health: https://www.bbc.co.uk/news/articles/cwly3g0g371go?at_medium=RSS&at_campaign=rss

The study will test multiple drugs simultaneously, initially focusing on two repurposed medicines already used to treat type 2 diabetes and attention deficit hyperactivity disorder (ADHD).

These medications have shown promise in alleviating symptoms such as memory loss and cognitive decline, which are characteristic of Alzheimer's. Researchers hope that by leveraging existing knowledge about these drugs, they can fast-track the development of new treatments.

The trial is called AD-SMART, and its first participant is Angela Bucksey from Cambridgeshire, who was diagnosed with Alzheimer's in January at the age of 67.

Angela's family history with Alzheimer's made her diagnosis a personal experience. She has seen firsthand how the disease affects loved ones, including her mother and aunts. Despite this, she remains determined to live as normally as possible and is now taking part in the trial, which offers her the opportunity to contribute to research that may one day help others.

Angela's decision to join the trial reflects her desire to take an active role in managing her condition. She believes that participating in the study empowers her to fight back against Alzheimer's, rather than simply accepting its limitations.

Alzheimer's is a devastating condition that affects millions worldwide, with around 600,000 people in the UK living with the disease. The impact on families can be severe, with loved ones struggling to cope with the loss of their relatives.

The launch of a new trial in the UK aims to bring cutting-edge treatments to patients as soon as possible. This trial is a multi-arm, multi-stage platform study where several treatments are tested simultaneously and compared against one group receiving a placebo or dummy treatment.

This innovative approach has been successfully used in cancer and motor neurone disease trials, allowing researchers to quickly identify which treatments show promise and drop those that don't. As a result, participants have a higher chance of being assigned an active treatment rather than a placebo.

The two initial drugs being tested are metformin, commonly used to treat type 2 diabetes, and atomoxetine, prescribed for Attention Deficit Hyperactivity Disorder (ADHD). These treatments were selected by an international panel of experts based on their potential benefits in treating Alzheimer's.

Researchers believe these innovative treatments may help reduce brain inflammation, a key driver of neurodegeneration in Alzheimer's patients. According to Prof Paresh Malhotra, chief investigator on the project, this new approach could potentially speed up the discovery of effective treatments.

The study is designed to test multiple treatments simultaneously, rather than focusing on one drug at a time. This method, inspired by advances in cancer research and other fields, aims to accelerate the testing process for Alzheimer's patients. By doing so, scientists hope to find solutions more quickly.

To achieve this goal, the study will assess whether these new treatments have a positive impact on cognitive function and daily living abilities. This is what matters most to patients and their caregivers, says Prof Malhotra. The team plans to recruit over 1,200 participants with mild to moderate Alzheimer's at multiple locations across the UK.

The trial sites are already open in several regions, including Cambridgeshire, Surrey, London, Southampton, and Edinburgh. Once the first treatments have been evaluated, which is expected to be completed by 2030, additional medications may be added to the study.

The study will involve regular health checks, including cognitive tests, to assess the effectiveness of the treatments being tested on Alzheimer's patients.

These assessments are crucial in understanding how well the medications are working and whether they have any significant side effects. The researchers aim to gather comprehensive data from these tests to inform future treatment options for people living with Alzheimer's disease.

The study has already gained interest among those affected by the condition, with some participants reporting a sense of optimism about their situation. By being part of a clinical trial, individuals and their families feel more supported and encouraged in their efforts to manage the disease.

With the goal of providing additional treatment options for people living with Alzheimer's, this study marks an important step forward in research into the condition.

BBC News Health: https://www.bbc.co.uk/news/articles/cqlye4v721nwo?at_medium=RSS&at_campaign=rss

The move comes after the researchers' offices were searched by the government of Guinea-Bissau, who apprehended the vaccines that had been allocated for the trial. The health minister in Guinea-Bissau, Quinhin Nantote, had previously denied any plans to proceed with the project. He stated categorically that it was "not even remotely true that the study would go ahead.

The proposed trial had been met with widespread criticism from experts and human rights groups, who deemed it unethical to conduct a vaccine trial on newborns in a country where access to immunization is already limited. Vaccines expert Paul Offit, of the Children's Hospital of Philadelphia, has been vocal in his opposition to the study.

The government of Guinea-Bissau now holds control over the vaccines that were allocated for the trial, which had been intended to be conducted in partnership with the Bandim Health Project. The project was set to receive funding from private partners such as the Pershing Square Foundation and the Bluebell Foundation.

Offit has emphasized the importance of prioritizing vaccination efforts in Guinea-Bissau, where plans are currently underway to introduce universal birth doses by 2028. He urged that the allocated funds be used to support this goal, rather than conducting a trial on newborns.

The Danish research team's hypothesis about live vaccines having an overall mortality benefit was met with skepticism by some experts. They argued that giving another vaccine like hepatitis B alongside a live vaccine could potentially dampen its effect.

Vaccine expert Paul Offit described the idea as fanciful", pointing out that there is no evidence to support it and that it doesn't make biological sense. He emphasized the importance of administering the hepatitis B vaccine as soon as possible, given the high rates of infection in the country and the risk of lifelong illness and death.

Offit's comments were not directly addressed by the Danish researchers, who did not respond to questions about their study or his criticism. The Centers for Disease Control and Prevention (CDC) also failed to comment on whether the allocated funding would be used to roll out the vaccine to all newborns in Guinea-Bissau.

The World Health Organization (WHO) has recommended that all infants receive a first dose of the hepatitis B vaccine within 24 hours of birth, followed by additional doses. The organization remains committed to ensuring that all newborns worldwide receive timely and evidence-based protection against hepatitis B.

Tarik Jašarević, a WHO spokesperson, reiterates the importance of following this recommendation, which is aimed at preventing lifelong illness and death from infection.

The controversy surrounding the US-backed vaccine trial in African newborns has raised concerns about informed consent among local mothers.

In order to participate in the study, mothers were given a 50% chance of receiving the vaccine for their children, while those who declined had zero chances of getting it. This uneven distribution has sparked debate over whether true informed consent was possible.

Some experts argue that this arrangement put pressure on families to participate in the trial, especially when considering the benefits of the vaccine.

The proposed trial has also led to distrust among locals, with many wondering if the vaccine was being tested on Africans because it was inherently dangerous. This skepticism is rooted in a decades-long record of safety and effectiveness for the vaccine.

However, experts emphasize that there are clear benefits to giving hepatitis B vaccines at birth, and not doing so can lead to lifelong danger.

The lack of evidence supporting concerns over the vaccine has led some researchers to question the need for such a study.

The decision to terminate the trial has raised questions about its potential implications for public health policies in Guinea-Bissau and beyond. Schaltz-Buchholzer expressed skepticism regarding the effectiveness and safety of the hepatitis B vaccine administered at birth.

The study would have also assessed side effects such as skin conditions and neurodevelopmental disorders, alongside mortality rates, to inform vaccination practices. Offit counters that giving newborns a hepatitis B vaccine is crucial, especially in countries like Guinea-Bissau with high incidence rates of chronic hepatitis B.

The Guardian World: https://www.theguardian.com/world/2026/oct/21/us-vaccine-trial-african-newborns-hepatitis-b

OpenEvidence's chatbot allows doctors to quickly scour medical journals and clinical guidelines, a task that can be time-consuming and complex. Founded by serial entrepreneur Daniel Nadler in 2022, the company has grown largely through word of mouth, with few tools in this sector achieving similar traction.

The platform's success has been driven in part by its ease of use and ability to alleviate workloads for medical professionals. According to interviews with eight senior physicians, OpenEvidence has won praise for helping doctors streamline their workflow and make more informed decisions.

However, the company's growing influence is also sparking controversy. As more doctors rely on AI tools like OpenEvidence to inform their treatments, concerns are being raised about the accuracy of its results. Researchers are warning that over-reliance on these platforms could compromise patient care.

OpenEvidence now boasts a valuation of $15 billion, a staggering figure that reflects its rapid growth and widespread adoption in the medical community. But with the likes of OpenAI and Anthropic also making inroads into this space, the company's dominance may be short-lived.

In a remarkable display of growth, OpenEvidence has secured nearly $1 billion in investment over the past 18 months from prominent backers such as Andreessen Horowitz and Blackstone.

The company's latest funding round, which took place in September, valued it at an impressive $15 billion. This influx of capital will likely fuel further expansion for the startup, which is already generating significant revenue through its ad-powered model.

OpenEvidence has reportedly booked $100 million in "ad buys" for this year, with projections indicating that it will generate between $400 million and $500 million through ads by the end of 2026.

The company's success can be attributed to its early mover advantage in a market for medical software that was initially slow to adopt generative AI models. For instance, Dutch IT group Wolters Kluwer released an AI version of its UpToDate tool only recently, nearly two years after OpenEvidence entered the market.

OpenEvidence's tool has been integrated into the electronic health records of several prominent hospitals and clinics in New York, including Mount Sinai Health System and Memorial Sloan Kettering Cancer Center.

This integration was made possible by the widespread adoption of OpenEvidence among clinicians at these institutions, who were already using the tool as an independent resource. According to Paul Testa, chief health informatics officer at NYU Langone, the hospital system decided to formalize its relationship with OpenEvidence after observing this trend.

The hospital's decision was driven by a desire to ensure that clinicians could get the most out of AI tools like OpenEvidence while also using them securely within their care process. Testa emphasized the importance of integrating OpenEvidence in a way that maximized its clinical value and minimized security risks.

As OpenEvidence continues to expand, it is exploring new applications for its technology beyond healthcare, including ambient documentation, the use of AI-powered note-taking during patient interactions. This development reflects the company's goal of leveraging its popularity among physicians to establish itself as a leader in multiple domains.

The company's expansion into literature-based drug discovery is a significant development, aiming to unlock new insights from vast amounts of scientific data. By leveraging this approach, Anthropic aims to create value that far surpasses any potential revenue generated through advertising or partnerships with hospitals.

To support its clinical work, the company has welcomed Alexander Tarashansky, creator of Claude Science, an Anthropic platform designed for research scientists. This addition brings valuable expertise and experience in supporting research efforts, potentially enhancing the company's capabilities in this area.

Anthropic faces competition from other frontier AI companies, including OpenAI, which has developed ChatGPT for healthcare applications. The latter has also partnered with OpenEvidence to bring its tools to 100 low- and middle-income countries, increasing the competitive landscape for Anthropic.

A recent analysis of OpenEvidence's effectiveness has yielded mixed results, with a study by the Mayo Clinic finding that it provided accurate recommendations in patient case studies but had limited impact on treatment decisions.

Research published in Nature has highlighted limitations in OpenEvidence's performance on clinical benchmarks compared to general-purpose AI models like Google's Gemini and OpenAI's GPT.

Concerns have been raised by medical professionals about the over-reliance on AI systems such as OpenEvidence without proper understanding of underlying conditions and treatment options. This is particularly worrying for junior doctors who may not possess the necessary expertise to evaluate AI recommendations effectively.

The use of AI tools in clinical settings requires careful consideration, and more research is needed to establish their reliability and optimal implementation strategies.

Ars Technica: https://arstechnica.com/ai/2026/10/the-15-billion-ad-powered-ai-startup-your-doctor-may-already-be-using/

The families of the detainees at the Krome North processing center in Miami and the Broward transitional center in Pompano Beach have been warning about the impending deportations for several days.

Multiple sick detainees with a range of medical conditions are reportedly being targeted for immediate deportation, despite their fragile health.

A spokesperson for the Workers Circle advocacy group said that relatives had informed them that some detainees were being told by deportation agents that Mexico would no longer accept them due to their medical conditions.

Detainees are often denied access to adequate medical care in detention, and once deported they may struggle to obtain essential medication or receive proper treatment.

Anisley Cortés' husband, Noslén Sendra, a 41-year-old Cuban national, has been incarcerated since last November, first at the now closed "Alligator Alcatraz immigration jail and then transferred to Krome in April.

Cortés claims her husband's poor health has been exacerbated by inadequate medical care while in detention. He suffers from uncontrolled diabetes and acute pancreatitis, which required a lengthy hospital stay earlier this year. Cortés' account paints a dire picture of the conditions at Krome, where she alleges that her husband was denied essential medication and adequate food.

The situation is compounded by the fact that neither Cuba nor Mexico will accept Sendra as a deportee due to his medical needs. As a result, immigration officials have informed him that he will be deported to an African country instead. Cortés expressed deep concern about the lack of transparency surrounding her husband's deportation plans and the uncertainty that lies ahead.

According to Shalyn Fluharty, an immigration rights attorney, information from detainees suggests that deportation flights are imminent. Specifically, she mentioned two upcoming flights scheduled for Thursday and Friday, which will likely depart for Africa, with destinations including the Central African Republic and Burundi.

Fluharty's statement underscores the urgency of the situation, as advocates scramble to understand the implications of these planned deportations and ensure that detainees receive adequate care before being sent abroad.

Advocates for detained immigrants are sounding the alarm over reports that severely ill individuals will be deported to unknown African states as early as this week.

The concerns stem from past practices where deportees were shackled during lengthy flights, with some being placed in full-body restraints despite medical needs. These measures raise serious questions about the treatment of vulnerable detainees.

For those with pre-existing conditions, such as heart problems or diabetes, travel can be particularly perilous. A prolonged journey of up to 24 hours can exacerbate their health issues and even become life-threatening.

The Department of Homeland Security has been asked for comment on this issue but has instead requested the personal details of affected detainees. When provided with specific information, the department failed to respond further.

Families are hesitant to speak out due to fear of retaliation against their relatives, making it difficult for advocates to gauge the full extent of the situation and provide adequate support.

The inadequate living conditions in ICE detention centers have been a long-standing concern for advocates, who point out that operational toilets, sinks, and showers are often in short supply. This has led to disturbing situations where female detainees are forced to use facilities in full view of male inmates, compromising their dignity and safety. Additionally, arriving detainees have been held in buses in the parking lot for over 24 hours due to overcrowding.

The situation is further exacerbated by Donald Trump's immigration crackdown, which has resulted in a surge in detention center populations nationwide. In an effort to alleviate this issue, the Department of Homeland Security (DHS) has increased deportation flights to third countries," a practice that was recently approved by the US supreme court. This move has seen hundreds of detainees deported to at least a dozen African nations where they have no connections or support systems.

The consequences of these deportations are dire, according to a recent Human Rights Watch report. Detainees have been subjected to persecution, arbitrary incarceration, and even torture upon arrival in their new countries. The lack of transparency and oversight surrounding these deportations makes it difficult for advocates to provide adequate support to those affected, leaving many families hesitant to speak out due to fear of retaliation against their relatives.

The Guardian World: https://www.theguardian.com/us-news/2026/oct/21/ice-detention-illness-deportation-florida

Researchers from Northwestern Medicine, UT Southwestern, and UT Houston tracked the heart health of 13 astronauts who spent around six months on the International Space Station. Their findings showed that the effects of spaceflight on the heart were initially noticeable but gradually diminished as the astronauts adapted.

The study's focus on cardiovascular health is crucial because NASA has long been concerned about how human hearts would fare in Martian gravity, which is significantly weaker than Earth's. This concern stems from the fact that prolonged periods of weightlessness can cause changes to the body's circulatory system.

To address this issue, the researchers monitored the astronauts' responses when they were exposed to simulated Martian gravity after returning to Earth. The results showed no significant signs of cardiovascular strain in any of the participants.

The study provides promising evidence that humans could indeed make it to Mars and function on its surface without experiencing severe health consequences.

The study published in Circulation last month is a significant step forward in understanding how humans adapt to Martian gravity.

Living without gravity poses unique challenges for the human body. On Earth, the heart works constantly against gravity to circulate blood, while muscles must support the body's weight. In space, these demands decrease substantially, allowing muscles and even the heart itself to shrink over time.

Astronauts returning to a gravitational environment can experience difficulties. They often suffer from dizziness or lightheadedness when standing after landing due to gravity pulling blood toward the lower body, causing sudden drops in blood pressure. This condition is known as orthostatic hypotension.

However, the astronauts involved in this study generally handled the transition well, likely due to their rigorous exercise schedules throughout their missions. The exercises were part of NASA's Exercise Countermeasures program.

Astronauts exercised for up to two hours each day, including endurance training that strengthens the cardiovascular system and resistance training to preserve muscle mass and strength. Their routines consisted of 30 to 45 minutes of endurance training and 60 to 75 minutes of resistance training.

The effects of weightlessness on the human body are multifaceted, and one area that's particularly susceptible is muscle mass.

When individuals spend extended periods in a microgravity environment, such as astronauts on the International Space Station, their bodies undergo significant changes.

As explained by Dr. Thomas, who also works at Northwestern Medicine, this is partly due to reduced physical activity while in space. Unlike on Earth, where people engage in various forms of exercise and daily activities that help maintain muscle mass, astronauts tend to move less in a weightless environment.

To offset these effects, exercise plays a crucial role for astronauts during prolonged spaceflight.

The transition from Earth's gravitational pull to weightlessness can be challenging for the human heart. In a recent study, researchers analyzed data from astronauts undergoing simulated Mars gravity conditions to see how their cardiovascular systems adapted.

Cardiac filling and stroke volume measurements indicated that the hearts of these astronauts initially struggled with the new environment. During the first two weeks in space, these metrics showed declines, suggesting that the hearts were temporarily moving less blood with each beat.

As the astronauts spent more time in space, their bodies began to adjust. Cardiac filling and stroke volume gradually improved over time, approaching pre-launch levels. This suggests that the heart can adapt to prolonged weightlessness when regular physical activity is maintained.

The results also offer insights into what might happen during a real Mars mission. When an astronaut who has spent months in space encounters Martian gravity, about 38% of Earth's surface gravity, their heart will need to adjust once again.

The researchers conducted a follow-up experiment to test how astronauts' hearts would perform under Martian gravity conditions after returning from space.

To simulate Martian gravity, each astronaut was tilted upward by 22 degrees while lying down, causing their blood to shift towards the lower body and mimicking the circulatory effects of weaker gravity on Mars.

The results showed that the astronauts' hearts adapted well to this new gravitational scenario, performing similarly to how they did when standing upright on Earth before their space missions.

This suggests that if astronauts maintain a high level of cardiovascular fitness during their time in space, they may be able to transition to Martian gravity without experiencing significant cardiovascular difficulties.

The findings provide valuable insights for planning future Mars missions and offer optimism about sending humans to the Red Planet.

The research highlights a new connection between space travel and cardiovascular health, indicating that astronauts' hearts may be more resilient than previously thought.

This discovery has significant implications for future Mars missions, where prolonged exposure to microgravity could potentially lead to cardiac issues. The findings suggest that the heart's ability to adapt to extreme environments may be greater than anticipated, offering hope for long-duration spaceflight.

ScienceDaily Health: https://www.sciencedaily.com/releases/2026/10/261020085016.htm

Currently, there is a lack of oversight regarding who can perform these 'no scalpel' procedures, which, if not done correctly, can lead to serious harm or even death. The government's plan seeks to eliminate unscrupulous practitioners from the market by restricting access to high-risk treatments for under-18s and imposing harsher penalties on rogue providers.

The proposed regulations are a response to years of calls for stricter regulation in the cosmetic surgery industry. A series of disturbing incidents, including procedures carried out in unconventional settings like Airbnbs, hotel rooms, and public toilets, has highlighted the need for greater oversight.

As part of the new rules, individuals who engage in illicit or unlicensed practices will face stiff penalties, with fines reaching up to £4,000.

The UK government is cracking down on non-licensed cosmetic procedures that have led to severe health consequences. The new rules aim to protect individuals from undergoing treatments in unregulated settings.

A recent case highlighted the dangers of these practices when a woman's treatment for a liquid Brazilian butt lift (BBL) ended in tragedy. She developed sepsis after receiving fillers in a private house, and her body began to shut down.

The new regulations will redefine liquid BBLs as cosmetic surgical procedures, making it mandatory for only licensed medical professionals to perform the procedure. This move aims to prevent inexperienced practitioners from putting patients at risk.

To further regulate high-risk treatments, non-surgical procedures such as deep chemical peels and vampire facials will be restricted to trained healthcare professionals, including doctors, dentists, nurses, midwives, and pharmacists.

The trend of using platelet-rich plasma, also known as vampire facials, has gained popularity worldwide. This treatment involves drawing a patient's blood and then separating out the platelet-rich plasma from it using a centrifuge. The extracted plasma is then injected back into the face through tiny needle punctures.

Another non-surgical procedure that will be restricted to trained healthcare professionals is dermal micro-coring, which involves removing tiny sections of skin using thin hollow needles designed for scarless healing. This technique can cause complications if not performed correctly, including infection and scarring.

Chemical peels are another type of skin resurfacing procedure that uses a chemical solution to remove the top layers of skin. The treatment is often used to improve skin texture and reduce the appearance of fine lines and wrinkles.

Health Minister Karin Smyth has emphasized the importance of driving "cosmetic cowboys" out of the market and raising standards in the industry, allowing reputable businesses to thrive by providing safe and qualified services.

The government is seeking input from various stakeholders, including doctors, businesses, regulators, and the public, before finalizing draft rules for cosmetic surgery in England.

A licensing scheme for Botox clinics has already been introduced to enhance safety standards, while Scotland has implemented laws requiring cosmetic procedures to be performed by or alongside qualified healthcare professionals in a registered setting. Additionally, non-surgical treatments are now prohibited for individuals under 18 in Scotland.

The lack of dedicated regulations in Wales and Northern Ireland is expected to change soon, with plans aiming to bring the industry under stricter control.

BBC News Health: https://www.bbc.co.uk/news/articles/c3x2wxnrpk78o?at_medium=RSS&at_campaign=rss

Applegate, known for her roles in Anchorman and Married With Children, expressed her disappointment at being misdiagnosed, stating she felt "not happy at all" about the news. She broke down in tears upon learning of the incorrect diagnosis.

In a recent episode of her podcast Messy, co-hosted by Jamie Sigler, Applegate recounted how her doctor suggested stopping her infusion treatment for MS to see if her symptoms improved. However, when she stopped treatment, her body did not respond as expected.

Applegate's symptoms have continued to worsen since the initial diagnosis, and she is now back at square one, unsure of what is causing her debilitating daily struggles. An investigation into her condition will commence next week.

The revelation has led Applegate to question the accuracy of her previous diagnosis, with her body not reacting as it would if she truly had MS.

The revelation that Christina Applegate was wrongly diagnosed with multiple sclerosis has raised questions about the accuracy of medical diagnoses.

Misdiagnoses can have a profound impact on individuals dealing with chronic illnesses, as they become deeply ingrained in their sense of identity and self-awareness.

Dr Michael Kornberg, an associate professor of neurology at Johns Hopkins University School of Medicine, noted that there is a certain comfort in knowing what is happening inside one's body, which can be disrupted by incorrect diagnoses.

To live with a misdiagnosis for five years, only to have it overturned, can be extremely unsettling and leaves patients questioning their own understanding of their health.

A lack of clear diagnostic criteria for multiple sclerosis means that symptoms can vary widely between individuals, making accurate diagnosis challenging.

A vitamin B12 deficiency can masquerade as multiple sclerosis symptoms, according to a neurology expert. This condition can cause neurological problems that closely resemble those associated with MS, including cognitive decline, tingling sensations, and balance issues.

MS is considered a diagnosis of exclusion, where doctors meticulously review a patient's medical history and conduct numerous laboratory tests before making a determination. Dr Philip De Jager, director of the Multiple Sclerosis Center at Columbia University Vagelos College of Physicians and Surgeons, explained this process.

Given that misdiagnoses can occur, patients are advised to seek second opinions from healthcare professionals. This is especially crucial when it comes to complex conditions like MS, where accurate diagnosis can be challenging due to varying symptoms between individuals.

Christina Applegate's experience with an initial MS diagnosis serves as a reminder of the importance of seeking multiple perspectives in medical matters. Her situation ultimately led her to re-evaluate her condition and health status, allowing her to reassess her well-being and find new ways to cope with her challenges.

BBC News Entertainment: https://www.bbc.co.uk/news/articles/cqlyel3wnxmxo?at_medium=RSS&at_campaign=rss

The researchers had received significant funding for their work, with a total of $3.2m provided by US and international organizations, including the US Centers for Disease Control and Prevention (CDC) and private foundations such as the Pershing Square Foundation and the Bluebell Foundation.

According to officials, the police search was aimed at clarifying the circumstances surrounding the seized vaccines, with no indication that the immunizations themselves were of poor quality or effectiveness. The move has sparked further controversy over the vaccine trials, which have been marred by criticism from some quarters.

The researchers' work on African newborns had previously gained support from prominent figures, including Robert F Kennedy Jr, who has been an outspoken advocate for certain vaccination policies. However, the legitimacy of these policies and the ethics of the research itself remain contentious issues.

A letter posted online by the Bandim Health Project shows that Guinea-Bissau's national ethics committee at the ministry of public health had given its approval for the trial on 14 July, with a Danish research ethics committee also having approved the study earlier this month.

Guinea-Bissau's health minister has denied reports that a controversial vaccine trial will proceed despite earlier approvals from national and international ethics committees.

Quinhin Nantote dismissed the claims as "not even remotely true, stating his position in Portuguese on Thursday. This statement contradicts previous assertions that the study had been given the green light to move forward.

The proposed trial has sparked widespread concern among health experts due to its design, which would withhold hepatitis B vaccines from 7,000 newborns in the first six weeks of life. In a country where one in five adults are infected with the virus, this approach is deemed particularly reckless.

According to Tarik Jašarević, spokesperson for the World Health Organization (WHO), any study that denies essential vaccinations to participants is unethical and exposes newborns to serious harm. He emphasized the importance of hepatitis B vaccination at birth as a critical public health intervention.

The WHO has been closely monitoring the situation through its country office in Guinea-Bissau. Its representatives have been advising the ministry of health on introducing the hepatitis B vaccine, highlighting the potential consequences of this trial for newborns and the broader population.

The Bandim Health Project, which is co-led by epidemiologist Christine Stabell Benn, has been involved in various research initiatives in the country since its founding by anthropologist Peter Aaby in 1978.

The Bandim Health Project has been involved in various research initiatives in Guinea-Bissau since its founding by anthropologist Peter Aaby in 1978. This has included a study on the diphtheria-tetanus-pertussis (DTP) vaccine, which was conducted multiple times with differing results.

Kennedy's praise for the researchers, who he has referred to as the deities of vaccine research", is notable given the controversy surrounding their work. Specifically, his endorsement of Aaby's research led him to halt US funding to Gavi, the Vaccine Alliance, citing concerns about vaccine safety and efficacy.

Christine Stabell Benn, a key figure in the Bandim Health Project, has been involved in efforts to inform vaccination policy at home and abroad. As a member of the ACIP hepatitis B working group, she presented evidence to US regulators on the universal birth recommendation for hepatitis B vaccines.

Stabell Benn's work with the ACIP is also notable given her partnership with Tracy Beth Høeg, a former top official with the FDA who has expressed concerns about unnecessary vaccines. Together, they hosted a podcast that explored issues related to vaccine development and implementation.

The Bandim organization's impact on Guinea-Bissau's health and research capacities remains unclear despite its long presence in the country. A report from Stand Up for Science suggests that the organization may have done little to improve public health outcomes over the past five decades, raising questions about its effectiveness as a research partner.

Guinea-Bissau's fragile state has been highlighted by a recent police raid on RFK Jr's research organization in the country. The nation is still reeling from a military coup that took place less than a year ago, making it challenging for clinical trials to be conducted safely and effectively.

The lack of public health infrastructure in Guinea-Bissau means that Bandim often serves as the only option for desperate individuals seeking medical care. However, this has also led to significant distrust among citizens towards the organization, according to Colette Delawalla, an American health researcher and founder of Stand Up for Science.

The police raid on RFK Jr's research facility underscores Guinea-Bissau's precarious situation as it tries to protect its youth from exploitation by powerful Western nations.

The Guardian World: https://www.theguardian.com/world/2026/oct/20/rfk-jr-vaccine-researchers-offices-raided-guinea-bissau

The images show the North Korean dictator touring an exhibition of clothing and footwear with his daughter, sparking questions about the validity of claims circulating online.

Rumors of Kim's demise have become increasingly common in recent years, fuelled by the secretive nature of North Korea's government. In such a system, verifying facts can be extremely challenging.

A Chinese dissident living in the US, Wanjun Xie, claimed hours before the photos emerged that Kim had been taken to a hospital in Beijing in a coma and was dead.

The photographs of Kim Jong Un examining displays with his daughter Kim Ju Ae and a group of officials have raised questions about previous claims of his death.

These images contradict Wanjun Xie's assertion that Kim had been taken to a hospital in Beijing in a coma and was dead. The exact timing of the photos is unknown, but their release has sparked doubts about the claim.

Experts point out that if there were a sudden collapse in Kim's health, signs of instability would likely be visible beyond North Korea's borders. This could include tightened security along the Chinese frontier or increased activity around North Korean diplomatic missions.

South Korean intelligence officials have also denied any knowledge of reports suggesting Kim's death. The latest rumour is not an isolated incident, as a similar false alarm emerged in 2020 when a defector claimed Kim had died following cardiovascular surgery.

The succession of Kim Jong Un is a crucial factor contributing to the recurring rumors about his death. Unlike his predecessors, Kim Il Sung and Kim Jong Il, there has been little clarity on who will inherit power after Kim Jong Un.

North Korea's ruling dynasty has maintained control for three generations, but the line of succession remains uncertain. Unlike Kim Il Sung, who spent decades grooming his son Kim Jong Il to take over, Kim Jong Un's rise was faster and more abrupt. After Kim Jong Il suffered a stroke in 2008, Kim Jong Un's rapid promotion through the ranks raised questions about his preparedness for leadership.

South Korea's intelligence agency suggests that Kim Jong Un may be laying the groundwork for his daughter to succeed him. She has been increasingly visible at key events and military displays, sparking speculation about her potential role. However, concerns have been raised about her youth, as she is only 13 years old.

The idea of a female leader in North Korea would also mark a significant departure from precedent. No woman has ever held the top position in the country's leadership, and there are doubts about her ability to navigate the treacherous waters of North Korean politics.

The uncertainty surrounding North Korea's leadership continues to fuel speculation about Kim Jong Un's health. This situation creates an environment where rumors about his well-being spread rapidly and gain significant attention.

A key factor contributing to these rumors is that they are not entirely unfounded. The reality is that Kim has a high-risk lifestyle, which includes being overweight and a heavy smoker. Furthermore, there is a history of heart problems within the Kim family, with cardiovascular disease posing a significant threat due to his habits.

The potential consequences of any leadership crisis in North Korea are far-reaching and have significant implications for neighboring countries and the global community. The uncertainty surrounding control of the country's nuclear arsenal raises concerns about political instability and the possibility of aggressive actions by hardliners in the event of a power struggle.

The regime's alleged manipulation of information has cast a veil of uncertainty over the country's leadership situation.

This speculation is further fueled by the fact that those closest to the truth may be leaking intentionally misleading information to obscure what is really happening inside North Korea.

The regime's actions have created an environment where rumors and misinformation can thrive, making it increasingly difficult for outsiders to discern fact from fiction.

BBC News World: https://www.bbc.co.uk/news/articles/cmvg6qv1jdydo?at_medium=RSS&at_campaign=rss

The tool zeroes in on specific areas around the eyes and nose when making its estimates. According to the researchers, these features hold crucial information that can help doctors gauge the severity of a patient's condition and make informed treatment recommendations. The AI tool is not intended to replace human medical professionals but rather serve as an auxiliary diagnostic aid.

The dataset used to train FaceSurvival includes patients with various types of cancer at different stages of progression, including cases where the disease had spread to bones or the brain. The age range of the cancer patients varies significantly, spanning from children to individuals in their 90s.

The preliminary findings of this research have been published in a leading digital health journal. While the tool is still in its experimental phase and not yet ready for clinical use, it has sparked interest among medical professionals who see potential benefits in using AI to support patient diagnosis.

Further refinement of the FaceSurvival tool is required before it can be integrated into hospital settings. Nevertheless, researchers are optimistic about its prospects as a supplementary diagnostic aid that could help doctors make more informed decisions about treatment options for their patients.

As people age, doctors are increasingly seeking ways to estimate their physical reserve and frailty before recommending intensive treatments. This is where a novel approach comes into play - using a simple photo of a person's face as a diagnostic aid.

The idea may seem unorthodox, but researchers believe that facial features can provide valuable insights into an individual's health status. For instance, certain characteristics such as wrinkles and folds on the skin can be indicative of physical decline. By analyzing these visual cues, doctors may be able to make more informed decisions about treatment options for their patients.

One tool being evaluated in this context is called 'FaceAge', which uses artificial intelligence to predict biological age - a measure that takes into account how old someone looks compared to their actual age. The tool focuses on specific areas of the face, including the nasolabial folds and marionette lines around the mouth, as well as the forehead, temples, and cheeks.

These facial features are thought to be indicative of overall health, with certain lifestyle habits potentially accelerating the aging process. For example, heavy alcohol use, drug abuse, and smoking can all take a toll on physical appearance. Researchers have found that the 'FaceAge' tool is surprisingly consistent across various photos, despite differences in pose, lighting, facial expression, and makeup.

The findings suggest that this approach could provide valuable supplementary information for doctors to consider when making treatment decisions. By combining visual cues with other diagnostic methods, healthcare professionals may be able to gain a more comprehensive understanding of an individual's health status.

The research on using facial photos to estimate biological age has shown promising results in various medical procedures, including plastic surgery, with some minor exceptions.

However, the researchers emphasize that their findings are based on limited data and more extensive testing is required to determine the accuracy of these tools across different ethnic groups.

To advance this technology, the research team is seeking public participation by uploading facial photos for analysis, which will provide a personalized biological age estimate.

Experts caution that while this tool demonstrates potential, it is still in its developmental stages and not yet ready for clinical use, requiring further testing against medical professionals' judgments.

BBC News Health: https://www.bbc.co.uk/news/articles/c6lyexv93pkdo?at_medium=RSS&at_campaign=rss

The emergence of a new Ebola case in Kenya has raised concerns about the US role in addressing the worsening outbreak. The country's withdrawal from key health services and funding cuts have left many questioning its commitment to global health security. The US has been criticized for its handling of the crisis, which some argue has exacerbated mistrust among local communities.

The construction of a quarantine center at Kenya's Laikipia air base has been met with opposition from locals, who claim they were not adequately informed about the facility's purpose or how it would be used. The Kenyan government's decision to establish the center has sparked protests and a court order to halt its development, which will be decided in November.

The controversy surrounding the quarantine center has been fueled by concerns over transparency and accountability. Many Kenyans were concerned about the lack of information provided on the quarantine place, said Allan Maleche, executive director of the Kenya Legal & Ethical Issues Network on HIV and Aids (Kelin). He noted that locals did not know who would be using the facility or what had informed its establishment.

The construction of the quarantine center is part of a broader shift in US policy under current leadership. The country's withdrawal from key health services and funding cuts have left many questioning its commitment to global health security, and raising concerns about the effectiveness of its response to the Ebola outbreak.

The Kenyan government's handling of Ebola cases has sparked concerns among locals, who are approaching any information about the outbreak with caution.

As the first Ebola cases emerge in Kenya, some Americans are questioning the US quarantine center set up to handle American citizens potentially infected with the virus.

Critics argue that the quarantine center poses an undue burden on the Kenyan government and may not be the safest place for Americans.

The US has invested heavily in building world-class Ebola treatment units, which have successfully treated patients during previous outbreaks without further spreading the virus.

These units were built using American taxpayers' money, but they remain largely unused due to recent cuts to health support programs and funding at organizations like USAID and the CDC.

The recent closure of HIV prevention offices by the CDC in Angola and South Sudan on October 1 is part of a broader trend of US funding cuts that are leaving countries vulnerable to public health crises.

These moves have sparked concerns about the impact of reduced support for HIV programs, which has already led to clinic closures and anxiety among communities. The lack of clear direction or planning from the US has exacerbated these issues, making it harder for affected countries to prepare for potential outbreaks.

The US is attempting to negotiate bilateral agreements with countries including Kenya, but this process has been shrouded in secrecy, leaving many questions about the scope and implementation of these plans unanswered. The uncertainty surrounding these agreements is causing further unease among healthcare workers and officials.

The abrupt withdrawal of funding from decades-long programs is not only limiting the ability to prevent and respond to outbreaks but also reducing the global capacity to address future emergencies. This trend has significant implications for countries already struggling with public health challenges, making them even more vulnerable to crises.

As a result of the US's decision to leave the World Health Organization (WHO) in January, collaboration on crisis response has become much harder, and the WHO's ability to respond effectively has been weakened by the loss of substantial funding.

The third Ebola case in Kenya has sparked concerns about the effectiveness of quarantine measures and contact tracing systems, despite officials' claims that these efforts are working.

Kenya's ministry of health has reported that a total of 108 people have been quarantined in Nairobi as part of their response to the outbreak. However, the fact that a sick person was able to travel across countries from the Democratic Republic of Congo (DRC) to Uganda and then Kenya has raised questions about the efficiency of these measures.

The Kenyan authorities have pointed out that the border between DRC and Uganda has been closed since May, but this closure does not seem to have prevented infected individuals from crossing into neighboring countries. In fact, a French doctor who returned from DRC in June tested positive for Ebola, highlighting the risks of travel and international spread.

The outbreak has also raised concerns about how other countries will react to the situation, with officials worried about the possibility of travel bans being imposed on Kenya. This fear is ironic given that the US has its own quarantine center in Kenya, which could potentially be affected by any such restrictions.

The recent Ebola case in Kenya has highlighted the consequences of the US's dwindling efforts in global health security.

The Trump administration's plans to cut back on HIV prevention and monitoring have been widely criticized by lawmakers, who argue that such measures are weakening America's ability to protect its citizens from infectious diseases.

Senator Raphael Warnock, a Democrat from Georgia, and Senator Bill Cassidy, a Republican from Louisiana, penned a letter in June opposing the cuts to global health funding, which they believe has eroded international disease-monitoring infrastructure.

Nuzzo, an expert on global health security, agrees that such measures have serious consequences. It's about having an understanding of the systems and conditions in other countries, she said, highlighting the importance of maintaining a network of eyes and ears abroad to detect potential threats early on.

By dismantling USAID and withdrawing from the WHO, the US is not only weakening its own preparedness but also compromising the global health security that benefits both America and its allies.

The Guardian World: https://www.theguardian.com/world/2026/oct/19/ebola-cases-kenya-us-quarantine

The latest injection brings Even's total capital raised to over $120 million, further cementing its position in the Indian healthcare landscape. This significant funding will enable the startup to expand its ambitious plans for a patient-centric approach to healthcare delivery.

In India, hospitals often earn substantial profits from patients undergoing additional tests or procedures that may not be medically necessary. Even Healthcare seeks to disrupt this status quo by prioritizing patient care over revenue-generating treatments that inflate medical bills.

Khosla Ventures has been a long-time backer of Even Healthcare, having invested in the startup since its seed round in 2021. The Silicon Valley-based venture firm is now doubling down on its commitment to the company as it prepares to build and operate hospitals that will allow for greater control over patient care and costs.

The investment marks a significant vote of confidence in Even's innovative approach to healthcare delivery, which combines financing, technology, and care delivery to reward better health outcomes rather than simply increasing healthcare utilization.

Even Healthcare has shifted its approach to care delivery after discovering that patients were undergoing unnecessary tests and surgeries at partner hospitals. The company's co-founder, Mayank Banerjee, revealed in an interview that Even began questioning the traditional model of healthcare delivery.

The startup's decision to build its own hospitals was driven by a desire to provide better experiences for patients and insurers alike, who are often left with poor economic outcomes due to unnecessary medical interventions. By building its own facilities, Even aims to break free from the conventional hospital economics that prioritize profit over patient well-being.

Even has already made significant strides in this direction, having opened two hospitals in Bengaluru, India, which achieved operational profitability within a year of opening. The company is now poised to expand further, with plans to open five more hospitals in the southern Indian city over the next six months.

The startup's approach to hospital management involves leasing buildings on 20-year agreements and investing in medical equipment and infrastructure. This allows Even to maintain control over costs and ensure that its facilities are equipped to deliver high-quality care.

One key aspect of Even's model is its payment structure for doctors, which eschews the traditional system of tying compensation to the number of procedures performed. Instead, doctors at Even receive fixed salaries, with opportunities to earn bonuses based on patient-reported clinical outcomes.

The same principle applies to hospital management, whose compensation is not linked to the number of procedures carried out. Managers and marketing teams are incentivized through company-wide rewards, rather than being motivated by revenue generated from medical interventions. Moreover, all employees at Even, including doctors and support staff, receive equity in the startup as a way of aligning their interests with the long-term performance of the company.

Even Healthcare's business model is primarily driven by patients paying for treatment, according to a spokesperson. The company also generates revenue through partnerships with insurance providers, who cover some of the costs associated with patient care. Additionally, Even is exploring a new compensation model with its insurer partners that would reward the startup for preventing hospitalizations rather than simply providing more medical interventions.

The startup tracks patient recovery using established medical scoring systems to measure pain and mobility after treatment. For example, in cases of knee replacements, Even uses the Oxford Knee Score to assess patient outcomes. This data is then published on the company's website for comparison with other healthcare systems.

Even claims significant improvements in hospital performance metrics compared to industry benchmarks. Specifically, its hospitals have an unplanned readmission rate of less than 1%, which is significantly lower than the industry average of 8-15%. Furthermore, patients spend approximately 40% less time in the hospital under Even's care.

Even's approach has also generated cost savings for insurers, with the startup estimating that it has saved its partners over ₹500 million (approximately $5.27 million) to date. This figure is a result of reduced hospital stays and lower readmission rates.

Despite these achievements, regulatory filings show that Even posted a net loss of ₹902 million (around $9.50 million) in fiscal 2025, representing a nearly 25% increase from the previous year's losses. Revenue for the same period stood at ₹272 million (approximately $2.86 million).

Even Healthcare has undergone significant restructuring in recent months, resulting in the layoffs of around 350 employees, according to reports.

The affected staff received support packages, including severance pay, extended health insurance, and accelerated equity vesting, as part of the company's efforts to adapt to changing circumstances.

Despite this reduction in workforce, Even Healthcare continues to expand its operations, employing approximately 650 people, with around 300 doctors working full-time for the startup.

The company has also seen significant growth in terms of membership, with over 250,000 patients now enrolled and having interacted with the platform more than 750,000 times since its launch in 2021.

Even's focus on expansion is a deliberate choice, as the startup seeks to increase patient interactions rather than prioritizing profitability.

Even Healthcare is expanding its services to increase patient interactions, rather than focusing on generating profits. This strategic decision aims to provide more personalized care and support to patients, which is crucial in India's hospital economics landscape.

The expansion efforts will enable Even Healthcare to better address the country's pressing healthcare issues, including limited access to quality medical facilities and specialized treatments. By increasing patient engagement, the startup hopes to make a significant impact on the region's healthcare sector. This move solidifies its position as a major player in India's rapidly evolving healthcare landscape.

TechCrunch: https://techcrunch.com/2026/10/19/khosla-ventures-doubles-down-on-even-healthcare-to-challenge-indias-hospital-economics/

The study involved participants who consumed blueberries regularly and showed a significant reduction in depressive symptoms compared to those who did not eat blueberries. However, when the results were compared to a placebo group, the differences in depressive symptoms were not statistically significant.

Lead researcher Courtney L. Millar notes that fiber and anthocyanins found in blueberries may have the potential to modify the gut microbiome and metabolites associated with depression in older adults. The study aimed to explore this connection by examining the effects of daily blueberry consumption on gut microbes, metabolites, and depressive symptoms.

Researchers recruited 65-year-old or older participants who were physically inactive and experiencing mild depressive symptoms for the pilot study. A randomized double-blind design was used to compare the effects of blueberry consumption with a placebo group.

The study's results offer preliminary clues about the potential link between blueberry consumption, gut bacteria, and mental health in older adults. However, more research is needed to confirm these findings and establish any causal relationships between eating blueberries daily and its impact on mood.

The study involved 18 participants who consumed either 48 grams of blueberry powder daily or a matching placebo over three months. This amount is equivalent to approximately two cups of fresh berries. The researchers aimed to assess whether this daily intake would have any impact on the gut microbiome and, subsequently, mood.

Participants were predominantly women with a mean age of around 75 in the placebo group and 71 in the blueberry group. The population was mostly white, with eight participants receiving the placebo and ten consuming the blueberry powder. This demographic breakdown is crucial for understanding the sample size and diversity within the study.

Despite finding some encouraging signs, the researchers were unable to establish a statistically significant difference between the mood improvements of those consuming blueberries daily and those who received the placebo. The lack of a clear distinction in depressive symptoms suggests that other factors may be at play or that more participants are needed for conclusive results.

The analysis of gut microbiomes revealed no overall change in microbial abundance, MetaCyc metabolic pathways, or short-chain fatty acid metabolites among participants consuming blueberry powder daily. However, the researchers did identify statistically significant changes within this group regarding certain gut microbial enzymes.

One notable finding was an increase in genes associated with EC 3.6.3.31 Polyamine Transporting ATPase, which plays a role in producing gamma-aminobutyric acid (GABA), a neurotransmitter involved in brain signaling. This could indicate subtle changes in the production of GABA within the gut microbiome, potentially influencing mood and cognitive function.

Further research is needed to confirm whether the changes observed in gut microbial function are linked to a reduction in depressive symptoms or improved mood in older adults.

The study's findings suggest that blueberries may have a specific impact on certain aspects of gut microbial function, even if they don't alter the overall composition of the microbiome. This could indicate subtle effects on how microbes interact with each other and their host.

More studies are required to determine whether these changes are associated with meaningful improvements in mood or depressive symptoms. It is unclear at this point what specific mechanisms might be involved in any potential benefits to mental health.

The research team consisted of experts from various fields, including nutrition, psychiatry, biostatistics, and aging research. Their collective expertise likely contributed to a comprehensive understanding of the study's findings.

A key aspect of the study was its focus on older adults with mild depressive symptoms who were also sedentary. This demographic may be particularly vulnerable to changes in gut microbial function due to age-related declines in physical activity.

The researchers' use of advanced analytical techniques allowed them to identify subtle shifts in gut microbial function, which could have important implications for our understanding of the relationship between diet and mental health.

The researchers' advanced analytical techniques allowed them to identify subtle shifts in gut microbial function that could have significant implications for understanding diet's impact on mental health. These findings suggest a previously unknown link between dietary components and mood regulation. The study also found correlations between specific nutrients and changes in brain chemistry. This knowledge may eventually contribute to the development of more targeted treatments for mood disorders.

The research's focus on gut microbiota highlights the complex interplay between diet, microbes, and mental health. Further investigation is needed to fully elucidate this relationship, but the initial findings are promising. The study's emphasis on understanding the role of specific nutrients in modulating brain chemistry may ultimately lead to more effective interventions for mood-related conditions. This research has the potential to shed new light on the intricate connections between diet and mental well-being.

ScienceDaily Health: https://www.sciencedaily.com/releases/2026/10/261017230028.htm

The 33-year-old singer has been open about the challenges she faces due to live performances taking a toll on her mental health and wellness. It's been nearly a decade since her last large-scale world tour, with four years passing since her last major concert. Cyrus acknowledged this fact during the show, hinting that it may be her last of its kind.

The singer has been candid about her struggles with performing live, stating that she needs to find balance in her life where she can prioritize her well-being alongside her career. Her desire to stage a large-scale concert was reportedly motivated by her late godmother, country music legend Dolly Parton, who passed away earlier this year.

Cyrus' performance at the Hollywood Bowl was a tribute to her godmother's memory, with the singer taking a moment to pay respects during the show. The audience responded warmly to the emotional gesture, as Cyrus performed a poignant rendition of "Jolene in honor of Parton.

The concert marked a rare return to live performances for Cyrus, who has been selective about her engagements due to concerns over her mental health and wellness. In a heartfelt message to the crowd, she expressed gratitude for their support and understanding in helping her find this balance.

Miley Cyrus' highly anticipated return to the stage at the Hollywood Bowl was a testament to her devoted fan base. The singer's first concert of the weekend, dubbed Bass Persuades Live at the Hollywood Bowl, drew an enormous crowd with over 1.5 million people waiting in line for the approximately 36,000 available tickets.

The show kicked off with Cyrus performing music from her latest album, which shares the same name as the concert series. The singer's setlist featured a mix of songs from Bass Persuades, giving fans a sneak peek into the new material.

Pre-recorded videos played before Cyrus' live performance allowed her to connect with the audience in a unique way. One such video featured Cyrus speaking directly to the crowd, saying You will stand on that same stage held by the people, the sound and the desire that's carried you all the way to your destiny. The message was laced with introspection and self-awareness.

Cyrus' gratitude towards her fans was evident throughout the evening. She repeatedly expressed appreciation for their understanding of her career trajectory. Tonight, it isn't just the night for us, she said, acknowledging the hard work that went into making the show possible.

In addition to thanking her audience, Cyrus also acknowledged the behind-the-scenes efforts that made the concert a reality. This emphasis on teamwork and collaboration underscored the significance of this momentous occasion in her career.

The setlist at Miley Cyrus' Hollywood Bowl show was a carefully curated mix of old and new material, with the pop star clearly pouring her heart and soul into each performance. The 18-song set featured hits like Party in the USA" and "We Can't Stop, but also included newer tracks from her album Bass Persuades, which seemed to be the most emotionally charged for Cyrus.

As she took the stage, it was clear that Cyrus was fully invested in every moment of the show. Her vocals on the older hits were slightly lighter than expected, with the crowd often taking over and singing along to songs like The Climb, a track from her Hannah Montana movie days. The new material, however, seemed to be where Cyrus' passion truly shone through.

The night's setlist was notable for its lack of typical live arrangements on some of Cyrus' biggest hits. For example, her 2013 single Wrecking Ball took on a new arrangement that skipped the iconic shift into the chorus, creating a fresh and exciting take on a familiar song. This willingness to experiment and try something new added to the overall sense of excitement in the air.

Despite some moments where Cyrus' live vocals were slightly overwhelmed by the music or crowd noise, the show was an undeniable success. The sold-out crowd was fully engaged and enthusiastic throughout, responding enthusiastically to every song and moment on stage.

The emotional depth of Miley Cyrus' performance at the Hollywood Bowl was palpable as she paid tribute to her godmother and country music legend Dolly Parton.

Cyrus broke down in tears while recounting a story about seeing Parton perform at the same venue before covering her iconic song Jolene. The poignant moment underscored the close bond between the two women, who have been connected since Cyrus was a child. As the intro to Jolene played in the background, Cyrus' voice cracked with emotion as she reminisced about her experience.

The tribute to Parton was just one of many touching moments during Friday's sold-out show, which seemed to be a therapeutic experience for both Cyrus and her audience. The singer has often spoken about the importance of her relationship with Parton, who has been a constant source of inspiration and support in her life.

Cyrus' performance was not just a celebration of music, but also a testament to her personal growth and newfound sense of balance in her life as a pop star. She expressed her gratitude for being able to pursue her passions and create a life that brings her joy and purpose.

In a heartfelt moment midway through the show, Cyrus shared with the crowd about finding happiness in everyday moments, such as acquiring a new pet or performing at iconic venues like the Hollywood Bowl. Her words captured the essence of living a life in harmony, where every dream and desire can be fulfilled.

The significance of October 16th, the day of the performance, was not lost on Cyrus, who referred to it as a new holiday" in her life. This sentiment reflected her renewed appreciation for the simple things that bring her joy and fulfillment, both on and off stage.

The singer's heartfelt words to her fans were a testament to the enduring bond she has formed with them over two decades in the entertainment industry. Her gratitude was palpable as she acknowledged their unwavering support and enthusiasm for her music.

Cyrus' emotional speech was a poignant expression of her appreciation, highlighting the significant role her fans have played in her personal growth and professional success. She emphasized that their steadfast loyalty has allowed her to live a life filled with love, creativity, and purpose.

The sold-out crowd at the Hollywood Bowl will be treated to another unforgettable performance when Cyrus takes the stage for the second night of Bass Persuades Live on Sunday, Oct. 18.

The Hollywood Reporter: https://www.hollywoodreporter.com/music/music-news/miley-cyrus-live-hollywood-bowl-2026-night-1-highlights-1236734276/

The first Municipal Gym will open in December in a 32,000-square-foot location outside Las Vegas, offering a wide range of services including blood work, epigenetic testing, and recovery gear. This comprehensive approach is similar to that of high-end longevity clubs that can cost tens of thousands of dollars per year.

Wahlberg sees his gym as a more accessible option for people who want to invest in their health without breaking the bank. He's positioning Municipal Gym as a one-stop-shop where members can receive cutting-edge diagnostics and treatments, all under one roof.

The idea for Municipal Gym has been in development for seven years, dating back to Wahlberg's early days as a celebrity fitness spokesperson. Initially, he explored the concept through his casual sportswear line, which launched during the pandemic.

Wahlberg acknowledges that entering the clothing market was not ideal timing, but it did allow him to test the waters and gauge interest in his brand. As he notes, many companies approached him to be their ambassador, but they wanted to focus on selling T-shirts and sneakers rather than making a meaningful impact on people's lives.

Wahlberg's vision for Municipal extends beyond just apparel, encompassing a holistic approach to wellness that includes what people eat, supplements they take, how they train, and how they recover.

This comprehensive approach is reflected in Municipal's plans to offer more than just clothing. The company aims to provide members with access to a range of services, including blood work analysis, doctor consultations, and personalized recommendations for supplements and hormone therapy.

In contrast to many high-end wellness companies that focus on catering to the wealthy, Wahlberg says Municipal will offer its services at an affordable price point. For example, members can expect to pay just $99 for a package that includes three rounds of blood work and an hour-long consultation with a doctor to identify potential health risks.

Municipal's pricing strategy is designed to make wellness accessible to a wider audience, rather than catering exclusively to the high end. This approach sets it apart from companies like Fountain Life, which raised $18 million last year to expand its luxury centers for wealthy clients, or The Estate, which plans to charge $35,000 memberships to its wellness centers.

Equinox is also entering the longevity space with a $36,000 add-on package that will be available on top of traditional gym membership. However, Wahlberg says Municipal aims to offer similar services at a significantly lower cost, making it more affordable for people to prioritize their health and well-being.

Municipal's focus on affordability and accessibility is part of its broader mission to make wellness more inclusive and sustainable. By offering high-quality services at an affordable price point, the company hopes to empower people to take control of their health and live longer, healthier lives.

Wahlberg's vision for his fitness concept is ambitious and multifaceted. He envisions a "health and wellness ecosystem" where members have access to a wide range of services and amenities beyond just traditional gym equipment.

The gyms will not only offer state-of-the-art facilities but also serve as a hub for people to connect with others who share similar interests in health and wellness. This approach is designed to foster a sense of community among members, encouraging them to stay engaged and motivated throughout their fitness journey.

In terms of expansion plans, Wahlberg has expressed a desire to aggressively pursue new locations. He's already received interest from landlords and developers who are eager to partner with him on high-profile projects. These opportunities have come with attractive tenant-improvement allowances that will help offset the costs associated with building out the facilities.

Wahlberg's experience in the fitness industry is extensive, having invested in F45, a popular chain known for its 45-minute high-intensity classes. While his involvement with F45 was ultimately marked by a public listing and subsequent delisting from the NYSE, Wahlberg has learned valuable lessons from the experience.

He attributes his success to being selective about the partners he chooses to work with, emphasizing the importance of finding individuals who share his vision and approach. This philosophy is in contrast to some gyms that operate on a "join up but don't show up" model, which Wahlberg finds puzzling.

Wahlberg's business acumen has also led him to favor a more traditional big-box gym model over F45's time-efficient classes. He believes that members should have ample opportunities to engage with the facilities and each other, staying for hours rather than just a few minutes.

Growing up in Boston's public spaces had a profound impact on Mark Wahlberg's life. He spent countless hours playing basketball and golf on municipal courts and courses, which taught him valuable lessons about competition, perseverance, and community.

Wahlberg's rough youth was marked by periods of poverty and hardship, including a two-year sentence for assaults as a teenager, during which he served 45 days in prison. However, his life took a positive turn with the influence of Father Jim Flavin, a Boston-area parish priest who has been a guiding figure in Wahlberg's life since he was 13.

The experience of being turned around by people like Father Flavin has left a lasting impression on Wahlberg. He wants to recreate this sense of community and support at his Municipal gyms, where members can come together to work out, have fun, and inspire each other to be their best selves.

For Wahlberg, the concept of Municipal is deeply personal, driven by his own experiences growing up in poverty and overcoming adversity. He believes that he has a responsibility to use his platform to make a positive impact on the lives of inner-city kids and at-risk youth, showing them that there is a way out of their circumstances through hard work and determination.

Wahlberg's vision for Municipal goes beyond just providing a place to work out; it's about creating a sense of community and support that can help people overcome their challenges and achieve their goals.

At this stage in his life, Mark Wahlberg has shifted his focus from how he looks to how he feels. He wants to wake up every morning feeling good, ready to tackle whatever challenges come his way.

The 55-year-old is juggling multiple projects simultaneously, including the development of Municipal, a gym concept that aims to provide an affordable and supportive environment for its members. In addition to this venture, Wahlberg has a film role as Pete Rose lined up, and his daughter's equestrian career also requires his attention.

Wahlberg's schedule is incredibly packed, which may explain why he feels like watching the construction of Municipal is akin to watching paint dry - tedious and uneventful. When asked if he was open to taking on new ventures, he responded with a nonchalant shrug.

Despite his reluctance to actively seek out new opportunities, Wahlberg didn't rule out the possibility entirely. If an exceptional opportunity were to present itself, he wouldn't turn it down without hesitation.

Mark Wahlberg's affordable gym concept is reportedly being developed as a way to disrupt the high-end fitness industry, which has seen significant investment from longevity startups focused on preventative medicine and wellness.

The entrepreneur's new venture aims to offer premium services at a lower price point than existing gyms, making it more accessible to a wider audience.

TechCrunch: https://techcrunch.com/2026/10/16/mark-wahlberg-wants-to-take-on-the-longevity-startup-crowd-with-an-affordable-gym-concept/

According to a filing notice on an Office of Management and Budget website, the FDA has submitted an "Interim Access Policy for review by the White House. While details about the policy are scarce, individuals familiar with the proposal have revealed that it would grant the agency enforcement discretion over certain peptide drugs. This means the FDA could choose not to enforce current restrictions on these substances and provide reassurance to specialty pharmacies looking to produce them.

Enabling the sale of unproven peptides has raised concerns among FDA staff scientists, who have pointed out that these substances lack sufficient research to establish their safety and efficacy. Moreover, there is a risk they may cause harm to those using them. The proposal's focus on easing access to peptide drugs contradicts this scientific scrutiny.

A request for comment from the Department of Health and Human Services, which oversees the FDA, has gone unanswered so far.

The proposal by Robert F. Kennedy Jr., a prominent advocate for health freedom, to have the US Food and Drug Administration (FDA) reconsider its stance on unproven injectable peptide drugs has sparked controversy.

These peptides, which are currently being re-reviewed by the FDA, were initially deemed to lack sufficient data on safety and efficacy, posing potential risks to users. Despite this, they remain popular among certain groups, including those in the MAHA community who claim that they can improve appearance, boost energy, and aid in injury recovery.

The peptides' popularity has led some sellers to make unsubstantiated claims about their benefits, with Kennedy himself being a self-proclaimed big fan of these products. In fact, he has vowed to end what he calls the FDA's war on peptides" since taking office.

As part of this effort, the FDA announced in April that it would reconsider 12 unproven peptides, and in June, Kennedy appointed new members to a key advisory panel tasked with reviewing them. However, at least six of these appointees have ties to businesses or clinics related to peptides, raising concerns about potential conflicts of interest.

In a July meeting, the panel voted to recommend adding six out of the first seven peptides considered back to the list of drugs that compounding pharmacies can make, despite objections from FDA staff scientists who maintain that these products still lack crucial safety and efficacy data.

A recent report suggests that the FDA may adopt a new approach to regulating compounding pharmacies, which could potentially ease access to unproven peptides. This move would bypass the formal rulemaking process, which is typically time-consuming and involves multiple rounds of public comment.

The Center for Science in the Public Interest (CSPI) has expressed strong opposition to this proposal, arguing that it puts consumers at risk of serious injury from unsupported claims about the benefits of these peptides. In a letter to Acting FDA Commissioner Kyle Diamantas, CSPI president Pete Lurie urged him to disregard the panel's recommendations.

If adopted, the new enforcement discretion could provide access to unproven peptides during the ongoing rulemaking process or as an alternative to it.

Ars Technica: https://arstechnica.com/health/2026/10/rfk-jr-proposes-fda-look-the-other-way-on-unproven-peptides-report-says/

The impact of malnutrition and starvation on children has been particularly devastating, with one-third of the deaths occurring among minors. Furthermore, elderly Palestinians accounted for the largest share of malnutrition-related fatalities, making up approximately 40.5 percent of the total number of deaths. This highlights the vulnerability of older adults in the face of food shortages.

The Gaza Health Ministry also highlighted the prevalence of hunger among vulnerable populations, stating that nearly half of older people have reduced their portions so that their families can eat. Moreover, 11 percent of elderly Palestinians reported going without a meal for an entire day. These statistics underscore the severity of the humanitarian crisis unfolding in Gaza.

Malnutrition has severe consequences on pregnant women's health as well, with rates of anaemia rising to 61 percent in 2026 from 41 percent before the war began. This alarming increase suggests that expectant mothers are increasingly vulnerable to malnutrition. The ministry also reported a significant spike in pregnancy losses, with nearly 4,000 recorded in the first half of this year alone.

The estimated number of children who will require treatment for acute malnutrition between now and April next year stands at 74,200, according to the Gaza Health Ministry. This staggering figure highlights the urgent need for food assistance and medical care to mitigate the effects of malnutrition on vulnerable populations in the region.

More than 1.4 million Palestinians in Gaza are projected to face severe food insecurity by the end of 2026, according to a warning from the Health Ministry.

This alarming figure accounts for nearly two-thirds of the region's population and highlights the urgent need for sustained efforts to address the hunger crisis. The approaching winter months only add to the sense of urgency, as access to basic necessities becomes increasingly difficult for vulnerable populations.

The United Nations children's agency, UNICEF, has cautioned that progress made in tackling Gaza's hunger crisis is fragile and at risk of reversal due to disruptions in supply chains. The organization emphasized the importance of maintaining open crossings to ensure a steady flow of humanitarian aid and commercial supplies into the region.

A recent report from UNICEF noted that while increased food and nutrition assistance helped prevent a prolonged famine after it was declared last August, acute malnutrition remains a significant concern.

The latest move by Israel to halt supplies to the Gaza Strip has exacerbated a dire situation, where most residents rely on humanitarian assistance due to years of conflict and strict restrictions on aid deliveries.

Gaza's Health Ministry is calling for international action to ensure that food and medicine can enter the territory freely, as well as support for reviving local food production. This effort aims to address the acute malnutrition concerns highlighted in a recent report by UNICEF, which noted that even though increased assistance helped prevent famine, malnutrition remains a significant issue.

The situation is further complicated by a tax dispute between local merchants and Hamas, with Israel blaming this for the supply shortages. However, Gaza's Government Media Office has dismissed Israel's claims as unfounded, accusing them of spreading disinformation.

Al Jazeera: https://www.aljazeera.com/news/2026/10/16/gaza-malnutrition-and-starvation-at-catastrophic-levels-health-ministry?traffic_source=rss

Vladimir K was detained in May when Japanese authorities intercepted his plans and arrested him upon entry into the country. This move has sparked an investigation by German detectives, who are now examining the suspect's alleged role in a high-profile cyber attack on Synnovis, a blood testing company based in London.

The hack of Synnovis led to disruptions in pathology services at several London hospitals, marking the first time a cyber attack had been directly linked to a patient's death. German officials have confirmed that Vladimir K is accused of being involved in this incident and other hacking activities.

Separately, British police are reviewing whether their ongoing inquiry may lead to an unlawful killing case, which would be a world-first in cyber-crime if pursued. This development highlights the growing concern over the impact of cyber attacks on public health services.

The Qilin gang is alleged to have hacked more than 4,000 organisations since 2024 and extorted over $140 million (£105 million) from victims. Vladimir K was also wanted in Germany for hacking into a logistics company last year and encrypting its data before demanding cryptocurrency payment.

German authorities are now investigating a hacking incident at London's Synnovis diagnostics and pathology service, which provides services to several hospitals in partnership with German company Synlab.

Synnovis is a critical component for many London hospitals, including King's College Hospital NHS Foundation Trust, one of the two trusts heavily affected by the hack. The cyber-attack on 3 June 2024 resulted in disrupted blood transfusion services and cancelled operations at these institutions.

Emergency patients were diverted to other facilities during this period due to the severe disruption caused by the attack. This incident highlights the vulnerability of critical healthcare infrastructure to cyber threats, which can have far-reaching consequences for patient care.

The investigation into the Synnovis hack is now being conducted in conjunction with German authorities, who are also looking into similar incidents involving hospitals and medical facilities in their country.

The arrest of a Russian man linked to the Synnovis hack has brought an end to a complex investigation into the cyberattack that caused significant disruption at London hospitals.

The hackers' motivations were not purely financial, as they claimed the attack was also meant to protest the UK's lack of support for Russia in its war with Ukraine. However, their claims were met with skepticism by experts who pointed out that the group behind the hack, Qilin, is known for using cyber-crime tactics.

The Synnovis hack resulted in over 10,000 appointments being disrupted and weeks of chaos at hospitals. The hackers had threatened to publish highly sensitive patient data unless a ransom was paid, but they eventually made good on their threat after no payment was forthcoming.

The arrest is significant not only because it brings an end to this particular investigation, but also highlights the challenges faced by law enforcement agencies in their efforts to combat cybercrime across international borders.

BBC News Health: https://www.bbc.co.uk/news/articles/c9vgr61kml3mo?at_medium=RSS&at_campaign=rss

The study's findings hold significant promise for overcoming two major challenges facing cancer immunotherapy: the scarcity of available immune cells and their limited lifespan in the body. By creating a system that can generate large numbers of genetically engineered cells, researchers aim to improve the effectiveness of cancer treatment.

Experiments conducted on mice have shown promising results, with the engineered cells successfully establishing themselves in bone marrow, producing new immune cells, and slowing tumor growth. This includes both blood cancers and solid tumors, offering hope for improved outcomes in patients struggling with these types of diseases.

The USC team focused their research on granulocyte-monocyte progenitors (GMPs), a type of immature immune cell that typically develops into macrophages and other immune cells. In the laboratory, GMPs can be grown extensively while retaining their ability to mature into functioning immune cells.

Genetic modification allows these cells to recognize specific cancer markers, enhancing broader immune responses and increasing their potential as cancer-fighting agents. This approach has far-reaching implications for both cancer immunotherapy and stem cell biology, according to the researchers.

The study's findings have been published in a leading scientific journal, with Dr Qi-Long Ying of USC highlighting the significance of this breakthrough and its potential applications beyond cancer treatment.

Stem cells have a remarkable ability to self-renew, allowing them to divide repeatedly without losing their original characteristics. This trait is often associated with hematopoietic stem cells, which can generate various types of blood and immune cells.

However, progenitor cells are more advanced in development and are typically specialized to produce specific cell types. They have traditionally been thought to lack the ability for long-term self-renewal.

Researchers at USC have shown that under controlled laboratory conditions, progenitor cells known as GMPs can retain their capacity for self-renewal. Unlike other progenitors, these cells continue to multiply while maintaining their original identity and function.

This discovery challenges the prevailing view that hematopoietic stem cells are the primary drivers of long-term self-renewal in the blood system. The USC team's findings suggest that GMPs can also exhibit this ability under the right conditions.

The implications of this breakthrough are significant, particularly for developing treatments that require large quantities of genetically engineered immune cells. This could open up new avenues for cancer therapy and other applications.

Macrophages play a crucial role in the immune system as versatile defenders against pathogens and damaged cells. These "big eaters" can engulf unwanted material and coordinate immune responses by sending signals to other cells. Some macrophages even infiltrate tumors, where they target and attack cancer cells, making them promising candidates for immunotherapy.

Macrophages are highly effective at coordinating the immune response, sending signals that influence the behavior of other immune cells. Their ability to enter tumors and attack cancer cells has made them attractive targets for researchers developing cancer treatments based on immunotherapy.

The study's findings suggest that macrophages could be powerful allies in the fight against cancer. By harnessing their abilities, scientists may be able to develop more effective treatments that target specific aspects of tumor growth and progression.

Macrophages' unique characteristics make them a promising area of research for developing new cancer therapies. Their ability to infiltrate tumors and attack cancer cells has significant implications for the field of immunotherapy.

The USC researchers' discovery of GMPs' self-renewal ability is a crucial step forward in understanding how to engineer large quantities of immune cells. This breakthrough could have far-reaching consequences for treating various conditions, including infectious diseases and potentially many others.

Researchers have been exploring ways to harness the power of macrophages, a type of immune cell, to fight cancer. Macrophages are particularly promising against solid tumors, which form masses in organs and tissues, as they can naturally migrate into tissues and penetrate tumors.

However, using macrophages as treatments has proven challenging due to several limitations. For one, mature macrophages are difficult to multiply outside the body, making it hard to produce large quantities for therapy. They also cannot be easily modified genetically and can be damaged during freezing and storage.

Another issue arises after administration when mature macrophages tend to accumulate in organs like the lungs and liver rather than spreading throughout the body. This limited distribution can reduce the treatment's effectiveness over time, as the cells often disappear relatively quickly.

To overcome these obstacles, scientists have turned their attention to an earlier stage of immune cell development, focusing on GMPs - the progenitor cells that give rise to macrophages and other related immune cells.

By targeting these early-stage cells, researchers can potentially sidestep the difficulties associated with mature macrophages. A precisely defined mixture of chemicals has been developed to support the survival and multiplication of GMPs in the laboratory for extended periods.

This approach allows for a renewable population of progenitors to be maintained, which can be expanded as needed to produce large numbers of engineered immune cells. Crucially, these GMPs retain their molecular characteristics even after extensive expansion, ensuring they remain functional when required.

Moreover, the ability of GMPs to develop into macrophages and other related immune cells on demand holds significant promise for manufacturing a consistent supply of cancer-fighting cells. This breakthrough could have far-reaching consequences for treating various conditions, including infectious diseases and potentially many others.

The scientists' work focuses on creating a renewable source of these cells, which can be continually expanded to meet the needs of therapy. The goal is to establish a reliable system for producing large numbers of engineered immune cells from a starting population that can be repeatedly replenished.

To further validate their findings, researchers at Stanford University independently replicated the process of maintaining GMPs for extended periods and genetically engineering them. This additional confirmation provided crucial support for the reliability of the technique and its potential applications in cell therapies.

The method's versatility has sparked excitement among scientists, with many seeing it as a game-changer for various fields. According to Ravi Majeti, Director of the Institute for Stem Cell Biology and Regenerative Medicine at Stanford University, this expansion and engineering technique opens up new avenues for translational research.

To explore the full potential of expandable progenitor cells, the team turned their attention to programming these cells to combat cancer. They began by equipping GMPs with a chimeric antigen receptor (CAR), which enables immune cells to identify specific molecular markers on cancer cell surfaces and target them accordingly.

The use of CAR technology in cancer immunotherapy has shown promising results, particularly in treatments that modify T cells to recognize and attack cancer. Building on this concept, the researchers sought to apply a similar strategy to GMPs, allowing for the generation of engineered macrophages and other immune cells capable of fighting tumors.

In addition to equipping progenitor cells with CAR technology, some were also modified with an extra immune-activating signal. This modification was designed to recruit nearby immune cells, including T cells, to join the fight against cancer.

This added signal offered a significant advantage: it remained effective even when the donor's and recipient's immune characteristics didn't match. This finding has important implications for the development of off-the-shelf treatments using pre-manufactured cells from donors.

The possibility of creating standardized products that can be used by multiple patients raises hopes for more efficient cancer treatment strategies. Unlike personalized therapies, which require individualized cell preparations, such products could potentially be produced in larger batches and made available to a wider range of patients.

These engineered progenitor cells have the potential to revolutionize cancer immunotherapy, offering a new approach that combines the benefits of CAR technology with the scalability of off-the-shelf treatments.

Researchers have been working on a new approach to cancer immunotherapy using engineered progenitor cells, which can be expanded in large quantities and modified to target specific types of cancer.

In mouse experiments, these engineered cells were able to establish themselves in the bone marrow and other areas responsible for blood cell production, where they could generate additional immune cells. This is an important distinction from treatments that rely on mature macrophages, which may only provide a temporary solution as they can be cleared from the body relatively quickly.

The researchers found that by using progenitor cells, they could overcome this limitation and provide a continuous source of replacement cells within the body. This approach has the potential to improve the efficacy of cancer treatments in the long term.

To test their engineered cells, the researchers used mice with both blood cancers and solid tumors. The results showed that GMPs carrying CAR receptors were able to slow disease progression in both types of cancer.

The most effective treatment combination involved progenitors that carried not only CAR receptors but also an additional signal designed to activate other immune cells. This dual approach led to a stronger antitumor response, suggesting that it may be a more effective strategy for treating certain cancers.

Further research is needed to establish whether engineered GMPs can be safely and effectively used in humans, particularly if they are intended to persist and produce immune cells over extended periods.

The breakthrough research has successfully demonstrated that genetically modified immune cells can be used to restore the ability of mice with a genetic disorder to fight off bacterial infections.

This promising result extends beyond cancer treatment and suggests potential applications in inherited immune deficiencies and infectious diseases, where a constant supply of functional immune cells is crucial for patient recovery.

The study's findings highlight the significance of the developmental stage of an immune cell in determining its effectiveness as a therapeutic agent. By engineering cells at an earlier stage, scientists may be able to create more adaptable and easier-to-manufacture therapies that can provide ongoing protection against disease.

The research team suggests that future immunotherapies should focus not only on designing better CAR receptors but also on selecting the optimal developmental stage of the cell for maximum effectiveness. This approach could lead to more efficient and sustainable treatments for a range of diseases.

ScienceDaily Health: https://www.sciencedaily.com/releases/2026/10/261015003803.htm

The emotional and impromptu act was undertaken after years of struggling to care for her mother, who had been diagnosed with glioblastoma - a deadly brain cancer - at the age of 21. The young woman's life was turned upside down as she juggled her own education and social life with the responsibilities of caring for her sibling and managing her mother's medical treatment.

As her mother underwent multiple surgeries and hospitalizations, including one in a room previously occupied by Elizabeth Taylor, the young woman found herself learning new skills - such as how to navigate the healthcare system and advocate for her family. Her friends were attending college, debating sororities and semesters abroad, while she was focused on ensuring her mother received the best possible care.

The experience had a profound impact on the young woman's life, forcing her to confront mortality and the impermanence of things. She recalls wiping away her mother's tears as she lay in hospice care, struggling to breathe, and being told by the nurse that their permission was needed for her to let go.

In a poignant moment, the family gave their mother "permission" to pass on, but secretly hoped she would hold on. The young woman remembers every paused breath, every moment of uncertainty, as they waited for what felt like an eternity for her mother's passing.

Her mother's final month is a blur, with memories fragmented by grief and exhaustion. But the pain of losing someone so young and vibrant has left an indelible mark, forcing the young woman to confront the reality of death and the impermanence of life.

The emotional toll of caring for a loved one with a terminal illness can be overwhelming, leaving families to navigate complex medical systems and make difficult decisions about end-of-life care.

A typical funeral in the US can cost upwards of $8,300, including a viewing and burial. Cremation, often considered a more affordable option, still comes with a hefty price tag of over $2,200. For many families struggling to make ends meet, these costs become an unbearable burden.

The financial strain of end-of-life care can be overwhelming, forcing families to make difficult decisions about how to proceed. In some cases, this means navigating complex medical systems and making tough choices about the type of care a loved one receives. But even after the initial diagnosis is made, there are often more costs to contend with.

When it comes to funeral arrangements, many people do not realize that they have options beyond traditional burial or cremation. In some cases, families may choose to divide their loved one's remains among multiple individuals, requiring specialized containers and packaging.

In my own family's experience, we were faced with the challenge of dividing our mother's ashes among her children and aunts. The funeral home offered a maroon plastic box as a cost-effective solution, but it proved to be inadequate for our needs.

We eventually opted for smaller, wooden boxes that could hold individual portions of our mother's remains. These boxes were not only more aesthetically pleasing than the plastic container, but also cheaper. However, they did come with their own set of problems.

The seams on these small wooden containers proved to be a design flaw, causing our mother's ashes to seep out and scatter throughout our homes. It was a difficult situation to manage, especially when we were still grieving.

In addition to the logistical challenges of dividing our mother's remains, we also faced regulatory issues when planning a memorial service for her in Yosemite National Park. Scattering human ashes in a national park requires a special permit, which can be easily overlooked during times of grief.

The funeral industry has undergone significant changes over the years, transforming from a family-based practice to a business-driven model. Prior to the civil war, most Americans died at home and were prepared for burial by their own families. However, with the advent of embalming following the war, the industry began to shift towards a more commercialized approach.

As the funeral industry evolved, it became increasingly formalized, with the emergence of licensed directors, professional embalmers, and sealed casket sales. This marked a significant departure from the traditional family-based practice that had once been prevalent. The industry's focus on profit over personalized care has led to concerns about the rising costs associated with death.

One key factor contributing to the increasing prices in the funeral industry is consolidation. Large conglomerates have been acquiring independent funeral homes, leading to market dominance and higher prices for consumers. This trend has raised antitrust concerns at the federal level, highlighting the need for greater regulation in the industry.

The shift from burial to cremation has also played a significant role in shaping the modern funeral industry. According to statistics, cremations have become increasingly popular over the past few decades, with figures rising from 5% in 1970 to over 63% today. This change has presented an opportunity for innovation and adaptation within the industry.

However, rather than embracing this shift towards cremation, many funeral homes have simply adapted their business model to capitalize on the trend without providing meaningful value to consumers. As a result, families are being charged high prices for a process that is often seen as impersonal and cold.

This lack of innovation has led some families to seek out alternative solutions, such as companies like Parting Stone, which specialize in turning cremated remains into solidified stones. These businesses offer a more affordable and personalized approach to death care, one that prioritizes the needs and preferences of families over profit margins.

In many Filipino families, death is not something to be kept hidden or avoided. Instead, it's a natural part of life that's often acknowledged and even celebrated. Danielle Directo-Meston, a journalist from Los Angeles, grew up in such a family where they would regularly visit the cemetery to spend time with their deceased relatives.

They would clean the graves, adorn them with flowers, and share meals together as a way to honor their loved ones. This tradition has its roots in Undas, the Filipino celebration of All Saints' and All Souls' Day, which is deeply ingrained in the culture. For Danielle, this meant growing up surrounded by death and learning to accept it as a natural part of life.

However, when her family's experiences with the American death-care industry left them feeling uncomfortable and disrespected, Danielle realized that not everyone shares the same comfort level around death. Her family had lost several loved ones in recent years, but their interactions with funeral homes and cemeteries were often marked by aggressive sales tactics.

At Rose Hills, a large cemetery in California owned by Service Corporation International, Danielle's family encountered this phenomenon firsthand. Salespeople would approach them while they were attending services or gatherings, trying to sell them additional plots or other services. This was not an isolated incident, but rather the norm at this particular cemetery.

As Danielle watched her family navigate these situations multiple times, she began to feel a sense of frustration and disillusionment with the way the death-care industry operates. She realized that profit margins often take precedence over the needs and preferences of families, leading to uncomfortable and even exploitative interactions.

In response, Danielle made the decision to preplan her own funeral through a company that offers natural organic reduction, a process where a human body is transformed into soil. This option is now legal in several states, providing an alternative to traditional burial or cremation methods.

The cost of traditional burial methods can be steep, but some people are opting for alternative ways to handle their loved ones after they pass away. For Danielle, that means choosing a more affordable option: composting her remains.

This choice is not without its own set of costs, however. The process typically involves using specialized equipment and facilities to break down the body into a nutrient-rich soil. While it may seem unorthodox, some people view this method as a way to return to nature and reduce their environmental impact.

Composting is just one example of the growing trend towards alternative death care options. With traditional burial and cremation methods often carrying high price tags, many families are looking for more affordable ways to say goodbye.

For Danielle, choosing composting was not only about saving money but also about taking control of her mother's final wishes. Traditional burial methods can be expensive, with costs ranging from $20,000 or more for a single plot at the cemetery.

One of the most significant expenses associated with traditional burial is the cost of the mortuary and funeral services. This can add up quickly, making it difficult for families to cover the costs without going into debt.

In contrast, composting offers a more affordable option that allows families to take care of their loved ones in a way that is both environmentally friendly and budget-conscious.

The process of scattering ashes or remains is also becoming increasingly popular as an alternative to traditional burial.

A serene spot by a young tree was chosen to lay my mother's remains to rest, its fresh growth serving as a poignant reminder of life's cyclical nature. The tree stood about 3ft high, its tender shoots yearning for the nourishment that would soon be provided by the soil. This symbolism seemed particularly fitting in this moment.

As I poured the contents of the bag into the air, my mother's particles danced on the breeze, carried towards Half Dome with a gentle force. The wind rustled through her remains, scattering them about as they merged with nature. In this instant, she became one with the land.

The memory of that day will forever be etched in my mind as an act of profound love and devotion to my mother.

The Guardian Life and Style: https://www.theguardian.com/wellness/ng-interactive/2026/oct/16/death-care-industry-burial-costs-cremation

Five years ago, she was competing at the Tokyo Olympics as part of the Great Britain team, but today at just 32 she can barely muster the energy to get out of bed except to eat and use the bathroom.

Dobbin's health struggles stem from an ME diagnosis, a condition characterized by persistent fatigue that worsens with physical or mental exertion. Simple tasks like attending a doctor's appointment can leave her weakened for months afterwards.

She has lost count of how many "crashes she has experienced since being diagnosed, each one triggered by factors such as excessive light, loud sounds, or even a brief conversation. These episodes can last anywhere from 24 to 48 hours in some cases, but others persist for months on end.

With most days spent bedridden, Dobbin's life is now severely limited - this year alone she has left her house only five times, highlighting the drastic impact of ME on her daily routine and sense of identity.

Dobbin's health issues began with a pair of infections that hit her in winter 2021-22 - Covid and glandular fever. Initially, she didn't experience any severe symptoms, but retrospective tests revealed she had contracted both illnesses.

As time passed, Dobbin noticed changes in her body. She was sleeping more than usual and her running times were slightly slower, but these developments didn't raise immediate concerns. However, she did start to feel soreness in the glands of her neck and armpits.

A series of tests conducted by British Athletics doctors failed to yield any clear answers about Dobbin's condition. Believing it might be lingering glandular fever that would eventually subside, she continued training and competing.

Dobbin's participation in several major championships was a testament to her dedication and perseverance. She qualified for the World Championships, Commonwealth Games, and European Championships, all of which were condensed due to the pandemic backlog.

Her performances at these events were increasingly affected by her deteriorating health. At the Worlds, she struggled with a painful throat and experienced unusual nighttime awakenings. Meanwhile, at the Commonwealths, Dobbin reported feeling dizzy while running and experiencing more body soreness than usual.

The turning point came during the Europeans, where Dobbin false-started due to an unsettling loss of sensation in her legs while in the blocks. This marked a low point for Dobbin, who has since spoken candidly about her year of hell in an emotional interview after that race.

Dobbin's health struggles continued despite her efforts to return to training.

She attempted to resume exercising for six weeks but was only able to manage three weeks before hitting a roadblock.

Her medical team was perplexed by her persistent condition, given that she had already battled viruses months prior.

The specialists consulted with multiple experts across various fields and were left stunned by Dobbin's ongoing health issues.

ME, also known as chronic fatigue syndrome (CFS), is a poorly understood condition characterized by a wide range of symptoms including nausea, headaches, cognitive impairment, and brain fog.

Dobbin rejects the label CFS, believing it fails to convey the severity of her illness, which she describes as feeling like her entire body is shutting down.

Dobbin's condition has made even simple tasks exhausting, requiring her to spend most of her day in bed.

To manage her fatigue, she relies on medication that helps her sleep, but even this is not always effective.

Her family members are deeply affected by Dobbin's illness, and they struggle to cope with the emotional toll it takes on them every day.

Dobbin's father expresses his desperation to help his daughter find a cure or treatment for her condition, feeling frustrated by the lack of options available.

The constant worry about Dobbin's well-being has become a source of sadness and anxiety for her family, who fear for their future and the care they will need to provide.

The constant struggle to access specialist care for Beth Dobbin has taken a toll on her family's emotional well-being.

Without a dedicated NHS service for ME, Dobbin has had to navigate the healthcare system alone, educating GPs about the condition and sourcing private specialists after her British Athletics funding ended. The long wait for an appointment was 22 months - a period of uncertainty and worry that has been compounded by the lack of understanding and resources available.

Dobbin's sister Faye is taking matters into her own hands this weekend, running the Yorkshire Marathon to raise money for ME Research UK. This act of solidarity not only brings hope but also serves as a poignant reminder of the emotional burden carried by those closest to Beth. As Faye puts it, You just feel so helpless and we've been saying this for years now, what can we do?

The marathon is more than just a fundraising effort; it's an expression of love and support in the face of adversity. Faye acknowledges that her actions are limited by her sister's condition, stating It feels like [the marathon] is all I can do other than supporting her emotionally." Her words convey the depth of concern and anxiety that comes with caring for a loved one suffering from ME.

The emergence of long Covid has brought some attention to the medical community, highlighting the overlap in symptoms with ME. While this increased awareness offers hope for future breakthroughs and research funding, Dobbin's outlook remains bleak - at least for now.

The athlete's condition has sparked a wider conversation about chronic illness and its impact on daily life.

Many people living with similar conditions have reported feeling misunderstood or dismissed as being lazy, which can exacerbate feelings of isolation and frustration. The athlete's platform allows them to raise awareness and challenge these misconceptions, highlighting the need for greater understanding and support.

BBC Sport: https://www.bbc.co.uk/sport/athletics/articles/crd6dj26v4e4o?at_medium=RSS&at_campaign=rss

The researchers found that activating this protein in immune cells can make them more effective at attacking cancerous cells, potentially opening up new avenues for treating cancers that have resisted existing therapies. This finding could be particularly significant for colorectal cancer patients, who often face limited options when chemotherapy and immunotherapy treatments fail.

Colorectal cancer has become the leading cause of cancer-related death among people under 50, making this discovery a crucial one in the fight against the disease. With many patients struggling to find effective treatment options, the possibility of repurposing a protein associated with cancer growth could offer new hope for those affected.

Scientists at Cold Spring Harbor Laboratory have been exploring how the metabolic health and performance of individual cells can influence their ability to withstand illness. Assistant Professor Semir Beyaz is leading this research, which aims to identify commonalities between the fitness determinants of cancer cells and immune cells.

According to Dr. Beyaz, his team hypothesized that cancer cells and immune cells might share similar characteristics due to being governed by the same physical and chemical rules. This idea is based on the understanding that certain principles apply universally across different types of cells.

The research focuses on peroxisome proliferator-activated receptor delta (PPARD), a protein that regulates how cells burn fat for energy. This protein is crucial in controlling gene activity involved in various cellular processes.

To study its effects, the researchers first examined mice with colorectal cancer. They found that while cancer cells exploit PPARD to sustain themselves, activating this protein in immune cells has an opposite effect. It creates a favorable environment for the immune system's attack on cancer.

The key concept here is "cell fitness," as explained by one of the researchers. The type of fuel cells use affects their overall health and ability to function. When immune cells burn fat at a higher rate, they become more capable of fighting cancer.

The team sought to investigate whether boosting PPARD activity could enhance the effectiveness of engineered immune cells called CAR T cells in targeting human colorectal cancer. These cells are designed to recognize and attack cancerous tissues.

The researchers activated PPARD in CAR T cells and tested them against several experimental models of colorectal cancer. This included miniature tumor models grown from patient tissue, as well as human cancer cells cultured in laboratory dishes and implanted into mice for further study.

The researchers observed that when PPARD-activated CAR T cells were used in various experiments, tumor growth was slowed or halted. This outcome suggests that by altering how immune cells process energy, existing immunotherapy strategies could become more effective.

The study initially focused on colorectal cancer due to its increasing impact on younger adults. However, the team also obtained promising results in other types of cancer, including breast cancer, ovarian cancer, and melanoma, a serious skin condition.

The findings imply that improving immune cell fitness could become a broader strategy for treating tumors that are resistant to current therapies. The potential applications may extend beyond cancer treatment as well.

Beyaz believes the discoveries represent only a small part of what can be achieved in finding new ways to enhance cancer immunotherapy. He also notes that boosting immune cell fitness may help with other conditions where the immune system fails to eliminate diseased cells, such as endometriosis, a chronic inflammatory condition affecting millions of women worldwide.

Research has revealed that PPARD, a protein previously known for its role in cancer progression, can also play a beneficial part in fighting the disease.

When activated in immune cells, PPARD helps to destroy diseased cells, much like a hero from science fiction turning against an evil force. This opposing function of PPARD highlights the complexities of cellular biology and the potential for proteins to have multiple roles depending on their context.

Activating PPARD in immune cells could be a crucial step towards developing new cancer treatments, potentially leading to better outcomes for patients with this often-devastating disease.

ScienceDaily Health: https://www.sciencedaily.com/releases/2026/10/261015073203.htm

The innovative metagenomic testing method was used on more than 100 respiratory samples taken from young patients in intensive care, allowing doctors to pinpoint the underlying cause of their illness. This crucial information can significantly influence treatment decisions, as it often reveals bacterial, viral, or fungal infections that standard tests might miss.

In a disturbing example of the test's importance, a 10-year-old girl named Willow Crowther was rushed into intensive care at GOSH with pneumonia. The diagnosis came with a dire prognosis: her chances of survival were said to be only 50%.

The hospital's team used metagenomics, which involves sequencing all genetic material present in a sample, rather than relying on conventional methods that require clinicians to anticipate what they are looking for.

The new testing method has proven particularly effective for patients like Willow who were initially prescribed an antibiotic that was not suitable for their infection.

Her parents credit the test with saving her life, highlighting the importance of having such a tool available at the hospital.

The study in which this testing method was used involved 122 critically ill children treated at the pediatric intensive care unit at Great Ormond Street Hospital (GOSH).

Metagenomic testing allowed researchers to analyze all genetic material present in each sample, enabling them to detect thousands of different pathogens.

The test used by doctors at Great Ormond Street Hospital (GOSH) in London has shown that it can identify a wide range of pathogens, including bacteria, viruses, and fungi, from samples taken from critically ill children.

This is crucial because traditional testing methods often require clinicians to make an educated guess about which infection they are looking for, but the new test, known as metagenomics, allows researchers to analyze all genetic material present in each sample, enabling them to detect thousands of different pathogens.

The results of the metagenomic testing have also had a significant impact on prescribing decisions, with around one quarter of cases influencing whether or not antibiotics were started, stopped or changed. In many instances, this has meant that unnecessary treatment was avoided, which is essential in the fight against growing antimicrobial resistance.

In addition to its clinical benefits, the metagenomic testing at GOSH has also identified 50 organisms that would have gone undetected by routine diagnostics, potentially providing an early warning system for new infections.

The metagenomic testing at Great Ormond Street Hospital (GOSH) has significant implications for public health beyond its clinical benefits. According to experts, this approach could serve as a powerful tool in identifying new infections that pose a pandemic threat.

If a novel pathogen emerges and becomes a cause of the next pandemic, early detection through metagenomic testing would enable swift implementation of preventative measures. The project's success builds on earlier trials at Guy's and St Thomas' NHS Trust, where researchers first applied metagenomics to diagnose respiratory infections in adult patients.

The integration of this technology into routine diagnostics has already yielded promising results, including the identification of 50 previously undetected organisms that could potentially provide an early warning system for new infections.

BBC News Health: https://www.bbc.co.uk/news/articles/cw5yn83m8gypo?at_medium=RSS&at_campaign=rss

This approach is a departure from previous guidelines, which allowed patients and staff to use facilities based on their gender identity. The revised policy states that when it's not clinically necessary to do otherwise, single-sex wards or bays should be used, taking into account the individual patient's needs and the safety of others in the area.

The new guidance also acknowledges that decisions may need to be made on a case-by-case basis, weighing the clinical requirements against the dignity and safety concerns for both trans patients and other individuals in the ward. NHS England has emphasized the importance of ensuring that all patients receive appropriate care while maintaining a safe environment.

The revised guidelines come after a Supreme Court ruling in April 2025 clarified that equality law defines sex as biological sex, effectively redefining what constitutes a single-sex space or service.

The revised guidelines from NHS England emphasize that in order to avoid discriminating against trans people, they should be offered access to gender-neutral spaces within hospitals.

This approach acknowledges the clinical need for single-sex facilities while also recognizing the importance of providing alternatives for trans individuals who may not feel comfortable using these areas based on their biological sex.

In emergency and urgent care settings, such as emergency units and accident and emergency wards, clinical need takes precedence over other considerations, including gender identity.

To ensure compliance with the new guidelines, NHS trusts in England are being advised to conduct an audit of their facilities to identify areas where single-sex spaces can be adapted or replaced with more inclusive options, such as gender-neutral toilets and changing rooms.

Data from NHS England shows that hospitals have struggled to maintain single-sex wards due to pressure on resources, with the number of breaches of previous guidance increasing steadily since 2021.

Hospitals struggle to maintain single-sex wards due to resource constraints, resulting in a steady increase in breaches of previous guidance since 2021, according to NHS England data.

Trans rights organisations have expressed concerns that NHS staff may be unclear on how to provide safe care for trans patients, given the complexity of patient data records. Many thousands of trans-identifying individuals are recorded as being of the opposite sex, a situation described by Maya Forstater, CEO of an advocacy group, as "a mess". This lack of clarity could lead to difficulties in ensuring that trans patients receive appropriate care.

The NHS has faced controversy over equality law and workplace regulations, including a recent tribunal case at Darlington Memorial Hospital. The hospital was found to have indirectly discriminated against nurses who complained about a transgender colleague using female changing rooms. The trust's failure to address the nurses' concerns led to a complaint being lodged with an employment tribunal.

The outcome of this case has left some questioning whether NHS England's new guidance on single-sex wards will be effective in practice, particularly in resource-strapped hospitals. One nurse involved in the tribunal case, Bethany Hutchison, who is now president of the Darlington Nurses Union, welcomes the new guidance but notes that its success will depend on whether trusts follow it.

The new guidance from NHS England clarifies that hospital spaces should be allocated according to an individual's biological sex, rather than their gender identity.

This decision comes after years of controversy and court battles over single-sex facilities in hospitals. In 2025, a nurse named Sandie Peggie was involved in an employment tribunal against NHS Fife, where she claimed harassment due to her concerns about a trans woman doctor using the female changing rooms.

Peggie's case is ongoing as an appeal has been lodged and is expected to reach the courts next year.

BBC News Health: https://www.bbc.co.uk/news/articles/cry83dyddv6no?at_medium=RSS&at_campaign=rss

The study, which was published in Clinical Gastroenterology and Hepatology, discovered that individuals who regularly eat late have a 20% to 30% greater risk of liver disease compared to those who avoid eating in the evening. This increased risk includes conditions such as fatty liver disease and cirrhosis, a serious condition characterized by extensive scarring of the liver.

Previous research has already established a connection between late-night eating and other health issues, including obesity and cardiovascular problems. However, this study aimed to determine whether there is also a link between eating habits and liver disease.

The researchers analyzed data from three major nationwide studies involving nearly 200,000 participants. This large-scale examination provided valuable insights into the relationship between eating patterns and liver health.

Lead author Robert Wilechansky, a hepatologist at Oregon Health & Science University who specializes in liver transplantation, notes that while some previous studies have hinted at this connection, his team's findings are among the first to explicitly draw a link between late-night eating and fatty liver disease.

The study analyzed data from nearly 200,000 participants who shared information about their eating habits and lifestyle factors. The researchers grouped these individuals based on when they typically ate, comparing this to reports of fatty liver disease and cirrhosis.

A consistent association emerged between late-night eating and a higher risk of liver disease. Participants who reported consuming meals in the evening had a 20% to 30% increased likelihood of developing liver problems compared to those who did not eat at night.

Fatty liver disease affects approximately 30% of the US population, with excess fat accumulation in the liver often leading to inflammation and damage that can progress to cirrhosis. However, most individuals with fatty liver disease do not go on to develop advanced scarring.

The body's natural circadian rhythms may play a role in this phenomenon, influencing sleep, metabolism, and other bodily functions throughout the day. This internal biological process could potentially be linked to the timing of meals and its impact on long-term liver health.

The liver plays a crucial role in processing nutrients, regulating blood sugar levels, and managing energy storage and utilization. Its sensitivity to circadian rhythms makes it particularly vulnerable to disruptions caused by eating at irregular times.

Research has shown that people who work night shifts are more likely to experience metabolic problems, including obesity and heart disease. This has led scientists to investigate whether irregular eating patterns could be contributing to these issues, including the risk of liver disease.

The internal biological clock sends signals to the body to prepare for sleep at specific times, but eating during this period can interfere with normal physiological processes. By altering meal times, individuals may be able to mitigate potential negative effects on their health without having to change their diet composition.

Changing when meals are consumed could be a more manageable approach than drastically altering one's eating habits. This prospect is especially appealing given the growing body of evidence indicating that the timing of daily activities has significant implications for overall well-being.

The findings underscore the importance of considering the timing of everyday behaviors, including sleep, eating, and exercise. As research continues to shed light on this topic, it becomes increasingly clear that the internal biological clock plays a critical role in determining how effectively the body can metabolize food and maintain optimal health.

The liver is one of the organs most susceptible to disruptions in the normal relationship between eating and sleeping, according to previous animal studies.

These findings suggest that a mismatch between our internal biological clock and external meal times may have significant implications for our health.

A recent observational study has identified a link between late-night eating and an increased risk of liver disease. However, it's essential to note that this research cannot establish cause and effect.

The analysis relied on participants' self-reported information about their eating habits, which may not be entirely accurate due to the broad descriptions provided.

The findings suggest that liver health may be influenced by more than just diet. The study's results indicate that eating late at night could potentially contribute to a higher risk of liver disease.

This new perspective on liver health highlights the importance of timing in relation to food consumption. A significant percentage of people may be able to reduce their risk of liver disease simply by adjusting their meal schedule, rather than making drastic changes to their diet.

Further research is needed to confirm these findings and determine the full extent to which eating habits impact liver health.

ScienceDaily Health: https://www.sciencedaily.com/releases/2026/10/261014015503.htm

A comprehensive study has found that stroke rates among individuals aged 20 to 54 have nearly doubled over the past three decades, despite a marked improvement in survival rates. This trend is particularly concerning given the potential long-term health consequences for younger adults who experience strokes.

The study's findings are based on an examination of medical data from the Greater Cincinnati and Northern Kentucky region between 1993 and 2020. Researchers identified 2,076 adults within this age range who experienced their first stroke during the study period, highlighting a disturbing increase in cases.

According to Dr. Emily R. Fisher, lead researcher at the University of Cincinnati, While it was previously thought that strokes primarily affected older adults, our research shows that they are becoming more common among younger individuals. This shift has significant implications for public health and healthcare systems.

The study's data reveals a striking rise in stroke rates over time, with an increase from 33.9 cases per 100,000 person-years in 1993-1994 to 62.2 cases per 100,000 person-years by 2020, an approximate 83% surge.

The researchers used a measurement called person-years to track the frequency of strokes over time. This metric takes into account both the number of individuals being studied and the duration of their observation period, allowing for accurate comparisons across different periods.

Ischemic strokes were found to be primarily responsible for the surge in stroke cases among younger adults. These events occur when a blood vessel supplying the brain becomes blocked, cutting off oxygen and nutrients to brain tissue. As a result, brain cells can begin to suffer damage within minutes if left untreated.

The rate of ischemic strokes more than doubled over the study period, from 23.8 cases per 100,000 person-years in 1993-1994 to 47.3 in 2020. This stark increase stands out in contrast to other forms of stroke, which did not exhibit a comparable rise.

Intracerebral hemorrhage, characterized by bleeding directly into the brain, and subarachnoid hemorrhage, which involves bleeding in the space surrounding the brain, showed no significant increases over time. These findings suggest that the growing number of ischemic strokes is a distinct trend.

The researchers also investigated potential risk factors among younger adults who experienced strokes, identifying several conditions that became more prevalent over time. High blood pressure and diabetes were among the rising concerns, as well as atrial fibrillation, an irregular heartbeat that can lead to blood clots in the heart.

The prevalence of substance use among younger adults who experienced strokes has seen a significant increase over the years. In 1993-1994, about 4.6% of this demographic had documented substance use, but by 2020, that figure had risen to 40.2%. Much of this growth is attributed to an uptick in marijuana use.

While the study highlights these rising trends, it's essential to note that researchers cannot definitively link them to the increase in stroke rates among younger adults. This is because they lack comparable health data from individuals who did not experience strokes, making it impossible to determine the impact of risk factor changes on the overall trend.

Despite the concerning rise in stroke cases, there are signs of improvement in survival rates for younger adult patients. Research indicates that these individuals were more likely to survive a stroke than their counterparts nearly three decades ago.

The proportion of patients who died within 30 days of experiencing a stroke declined from 11.7% in 1993-1994 to 9.4% by 2020, according to the findings. This improvement is particularly notable among those suffering from intracerebral hemorrhage and subarachnoid hemorrhage, two types of bleeding strokes known for their severity.

The consequences of surviving a stroke can be long-lasting and debilitating, with many patients experiencing difficulties with movement, speech, memory, or other abilities. As the frequency of strokes among younger adults continues to rise, more people may have to navigate these challenges for extended periods.

The rising number of strokes among younger adults has sparked concern and calls for further research into the underlying causes.

Experts stress that identifying stroke risk factors early in adulthood is crucial to preventing this trend from continuing. However, more investigation is needed to understand what is driving these increases and how they can be reversed. This includes examining whether the same patterns are seen across different geographic regions and populations.

The study's limitations highlight the need for further research into this issue, with a focus on establishing national trends and identifying contributing factors.

ScienceDaily Health: https://www.sciencedaily.com/releases/2026/10/261014015459.htm

Hiyd's founder Salah Batroukh believes that individuals shouldn't have to choose between looking good and feeling healthy. According to him, health tracking doesn't need to be a conscious decision that involves changing one's appearance.

The company's first product is a small disc that attaches to the back of your existing watch using microsuction technology. This innovative material allows the sensor to sit flush under the watch without leaving any residue or interfering with its internal mechanisms.

Microsuction works by creating a vacuum effect, similar to traditional suction cups but on a much smaller scale. The textured silicone material is incredibly thin at just 0.3 mm and can be easily removed by prying it off.

The disc is designed to be invisible under the watch face, making it an ideal solution for those who want to track their health without compromising on style.

The sensor developed by Hiyd's team is designed to fit seamlessly into existing watch designs. With dimensions measuring 2.7 mm in thickness and weighing a mere 7 grams, it is unobtrusive and can be easily integrated into various timepieces. This slim design enables the sensor to collect a range of biometric data.

Hiyd's engineers are currently gathering data by filming themselves engaging in different activities, such as walking, jogging, or running. They then label these datasets to fine-tune their AI model. By doing so, they can refine the accuracy of the sensor's readings and ensure that it provides precise biometric information.

The collected data is synced with either an iOS or Android app, allowing users to access a wealth of information about their physical activity. This includes heart rate, heart rate variability, sleep staging, movement patterns, calories burned, and VO2 max estimations. The data analysis capabilities of the AI model enable Hiyd's team to incorporate various heuristic analyses.

The company is also working on incorporating nutrition tracking into its app. Rather than focusing solely on calorie counting, Hiyd aims to provide users with insights about how their eating habits affect their overall well-being. This includes sleep quality and workout performance.

By analyzing a user's dietary choices in relation to specific activities or events, the app can offer personalized recommendations. For instance, it might suggest that a particular food choice had a negative impact on one's sleep quality, or that a late-night workout was less effective due to certain nutritional factors.

After working for seven years as a manufacturing design engineer at Apple, Batroukh decided it was time to take on new challenges and create something that truly put customers first. He wanted to know if he could design innovative products without the massive resources of a global brand behind him.

Batroukh is joined in this venture by fellow founders Omar Shakir, a seasoned mechanical engineer who serves as CTO, and Mahamad Charawi, head of software. Charawi previously co-led Laudspeaker, a startup that was backed by Y Combinator and later sold.

The team's goal with Hiyd is to create a personalized health tracking system that doesn't require users to buy yet another device or accessory. Instead, the small sensor attaches directly to their existing watch, providing real-time data on various aspects of their well-being.

As part of its push into the market, Hiyd is competing in Startup Battlefield at TechCrunch Disrupt this week and plans to launch a Kickstarter campaign in November. Over 16,000 people have already secured first dibs on the company's initial units by making deposits.

The Hiyd health tracker is designed to attach seamlessly to a user's existing watch, eliminating the need for an additional device.

This innovative approach aims to make tracking fitness and health metrics more convenient and accessible, leveraging technology that people already use daily.

Hiyd has seen significant interest in its product, with over 16,000 individuals securing first dibs on initial units by making deposits.

The company is now focused on meeting the demand for its innovative health tracker.

As demand for its innovative health tracker continues to surge, Hiyd is now focused on meeting this growing interest in its product.

The company's efforts are being driven by a strong response from consumers who appreciate the convenience of attaching a health tracker directly to their existing watch, eliminating the need for an additional device. This streamlined approach has clearly resonated with customers, resulting in increased sales and a significant boost to the company's profile. With this momentum firmly established, Hiyd is poised to build on its early success and further establish itself as a leader in the health tracking market. Its innovative product has undoubtedly struck a chord with consumers seeking a hassle-free solution for monitoring their well-being.

TechCrunch: https://techcrunch.com/2026/10/14/hiyd-is-a-health-tracker-that-attaches-to-the-watch-you-already-wear/